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ABSTRACT 
Chronic arsenic poisoning due to arsenic contamination of groundwater is a serious 
public health problem in Bangladesh and neighboring countries. Severe health effects 
associated with chronic exposure to arsenic include melanosis and several kinds of cancer. 
It is now generally agreed that the arsenic contamination of groundwater in Bangladesh is 
of geological origin. Arsenic naturally present in aquifers may be mobilized into drinking 
water by microbial action. 
The formation of a novel arsenic-selenium compound: seleno-bis (S-glutathionyl) 
arsinium ion, [(GS)2AsSe]
-
, and its subsequent excretion in rabbit bile has been 
demonstrated previously. This molecular basis for the in vivo antagonism between 
arsenic and selenium was discovered using X-ray absorption spectroscopy. There is 
growing evidence that, in Bangladeshi people who are suffering long term chronic low-
level arsenic poisoning, this antagonism is causing a selenium deficiency. Administering 
selenium supplements might provide a simple but highly effective treatment of the 
Bangladeshi arsenic poisoning.  
In order to examine the disposition of [(GS)2AsSe]
-
, a set of rabbits were 
intravenously injected with selenite, arsenite or both. Whole blood, red blood cell and 
plasma samples were collected at different time intervals within 2hrs after injection and 
cecotrope samples 24hr after injection. Samples were examined using X-ray absorption 
spectroscopy and both arsenic and selenium K-near edge spectra were recorded. 
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Speciation of arsenic and selenium will be discussed in this thesis. Results indicate that 
[(GS)2AsSe]
-
 is formed in blood very rapidly after injection of both arsenite and selenite, 
and then is removed from blood stream within 2hrs post injection. Results also show that 
[(GS)2AsSe]
-
 is assembled in red blood cells, with no [(GS)2AsSe]
-
 detected in plasma 
samples. [(GS)2AsSe]
-
 is also found in cecotrope samples after injection of both arsenite 
and selenite. 
The results of this study in rabbits will contribute to the understanding of chronic 
arsenic poisoning in humans. 
 
 
 
 
 
 
 
 
 
iv 
 
ACKNOWLEDGEMENTS 
First of all, I would like to express my deepest gratitude to my M.Sc. supervisor Dr. 
Graham George for giving me the chance to finish this project and his guidance, expertise 
and advice during my graduate studies. I am thankful to my committee member Dr. 
Ingrid Pickering, for her support, understanding and encouragement throughout my 
research.  I would not get this far without their help and supervision. 
I also would like to thank the other members of my Advisory committee: Dr. Jane 
Alcorn, Dr. Judith Smits, Dr. Pat Krone and Dr. Bernhard Juurlink for their valuable time 
and guidance at all levels of my research project. 
Thanks to all the members of the Molecular and Environmental Sciences group for 
their time and assistance in data collection and the discussion of data analysis during my 
project. I am especially thankful to Michele Moroz at the Laboratory Animal Services 
Unit for helping with the rabbit experiments and the blood sample collection. 
I also want to thank my parents. Thanks to my father Dr. Zuoxin Liu who always 
encourages me to face the challenge and gives my full support whenever I have 
difficulties. Thanks to my mother Guifang Li who takes care of me throughout the years 
and give me freedom to live my life. Thanks to my boy friend Eric Ren who gives me all 
his love and support during my thesis writing. In addition, I would like to dedicate this 
thesis to my grandmother who passed away last year. 
I acknowledge financial contributions from Canadian Institutes of Health Research 
(CIHR) for supporting my studies. 
Research described in this thesis was partially performed at the Canadian Light 
Source, which is supported by the Natural Sciences and Engineering Research Council of 
Canada, the National Research Council Canada, the Canadian Institutes of Health 
Research, the Province of Saskatchewan, Western Economic Diversification Canada, and 
the University of Saskatchewan. Portions of this research were carried out at the Stanford 
Synchrotron Radiation Lightsource, a national user facility operated by Stanford 
University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences.  
v 
 
                                   Table of Contents 
PERMISSION TO USE ...................................................................................................i 
ABSTRACT .....................................................................................................................ii 
ACKNOWLEDGEMENTS...........................................................................................iv 
TABLE OF CONTENTS...............................................................................................v 
LIST OF TABLES..........................................................................................................ix 
LIST OF FIGURES.......................................................................................................xi 
LIST OF ABBREVIATIONS………………………………………………..…….....xv 
Chapter 1: Introduction ............................................................................................ 1 
1.1 Selenium and Arsenic in the Environment............................................................... 1 
1.1.1 Selenium ................................................................................................................ 1 
1.1.2 Arsenic .................................................................................................................. 4 
1.2 Arsenicosis ............................................................................................................... 9 
1.3 Antagonism between Arsenic and Selenium .......................................................... 11 
1.4 Hypothesis and Objectives ..................................................................................... 14 
1.4.1 Hypothesis ........................................................................................................... 14 
1.4.2 Objectives ............................................................................................................ 15 
vi 
 
Chapter 2: Experimental Technique .................................................................. 16 
2.1 X-Ray Absorption Spectroscopy ............................................................................ 16 
2.2 Synchrotron Radiation ........................................................................................... 21 
Chapter 3: Materials and Methods ..................................................................... 24 
3.1 Animal Model and Treatment ................................................................................ 24 
3.1.1 Animal Model ..................................................................................................... 24 
3.1.2 Treatment ............................................................................................................ 25 
3.2 Sample Preparation ................................................................................................ 26 
3.2.1 Blood Sampling ................................................................................................... 26 
3.2.2 Cecotrope Sample Preparation ............................................................................ 27 
3.3 Data Collection and analysis .................................................................................. 28 
3.3.1 Data Collection .................................................................................................... 28 
3.3.2 Data Analysis ...................................................................................................... 28 
3.3.3 Standards Preparation .......................................................................................... 31 
Chapter 4: Disposition of Selenium after Injection of Selenite ................. 32 
4.1 Total Selenium Concentration in Blood after Injection of Selenite ....................... 32 
vii 
 
4.2 Speciation of Selenium in Blood after Injection of Selenite .................................. 34 
4.3 Speciation of Selenium in Cecotrope after Injection of Selenite ........................... 44 
4.4 Discussion .............................................................................................................. 46 
Chapter 5:Disposition of Arsenic after Injection of Arsenite .................... 48 
5.1 Total Arsenic Concentration in Blood after Injection of Arsenite ......................... 48 
5.2 Speciation of Arsenic in Blood after Injection of Arsenite .................................... 50 
5.3 Speciation of Arsenc in Cecotrope after Injection of Arsenite .............................. 60 
5.4 Discussion .............................................................................................................. 63 
Chapter 6:Disposition of Selenium and Arsenic after Injection of 
Selenite and Arsenite ................................................................................................ 64 
6.1 Selenium and Arsenic Levels in Blood .................................................................. 64 
6.1.1 Total Selenium and Arsenic Concentration in Blood after Injection of Arsenite 
Followed by Selenite ...................................................................................................... 64 
6.1.2 Total Selenium and Arsenic Concentration in Blood after Injection of Selenite 
Followed by Arsenite ...................................................................................................... 68 
6.2 Speciation of Arsenic and Selenium after Injection of Selenite and Arsenite ....... 70 
viii 
 
6.2.1 Speciation of Arsenic and Selenium after Injection of Arsenite Followed by 
Selenite ............................................................................................................................ 73 
6.2.2 Speciation of Arsenic and Selenium after Injection of Selenite Followed by   
Arsenite ........................................................................................................................... 80 
6.3 Speciation of Arsenc in Cecotrope after Injection of Arsenite and Selenite .......... 87 
6.4 Discussion .............................................................................................................. 91 
Chapter 7: General Discussion and Future Work ......................................... 93 
7.1 The Behaviour of Arsenic in the Absence and Presence of Selenium ................... 93 
7.2 Future Work ........................................................................................................... 96 
References…………………………………………………………....................................... 97 
 
 
 
 
 
 
ix 
 
List of Tables 
Table 4.1 Percentage of selenium as each selenium species in rabbit whole blood 
samples after injection of selenite…………………...................................37 
Table 4.2 Percentage of selenium as each selenium species in rabbit red blood cell 
samples after injection of selenite………………………………………...40 
Table 4.3 Percentage of selenium as each selenium species in rabbit plasma samples 
after injection of selenite…………………………………………………..43 
Table 5.1 Percentage of arsenic as each arsenic species in whole blood after injection 
of arsenite………………………………………………………………..53 
Table 5.2 Percentage of arsenic as each arsenic species in red blood cell fractions after 
injection of arsenite……………………………………………………..56 
Table 5.3 Percentage of arsenic as each arsenic species in plasma fractions after 
injection of arsenite……………………………………………………..59 
Table 5.4 Percentage of arsenic as each arsenic species in rabbit cecotrope sample 
after injection of arsenite…………………………………………………..62 
Table 6.1 Percentage of arsenic as each arsenic species in rabbit blood samples after 
injection of arsenite followed by selenite……………………………….77 
Table 6.2 Percentage of selenium as each selenium species in rabbit blood samples 
after injection of arsenite followed by selenite………………………….78 
Table 6.3 Percentage of arsenic as each arsenic species in rabbit blood samples after 
injection of selenite followed by arsenite……………………………….85 
x 
 
Table 6.4 Percentage of selenium as each selenium species in rabbit blood samples 
after injection of selenite followed by arsenite………………………..86 
Table 6.5 Percentage of arsenic as each arsenic species in rabbit cecotrope samples 
after injection of arsenite and selenite…………………………………..90 
Table 6.6 Percentage of selenium as each selenium species in rabbit cecotrope samples 
after injection of arsenite and selenite……………………...……………90 
 
 
 
 
 
 
 
 
 
 
 
xi 
 
List of Figures 
Figure 1.1 
Figure 1.2 
Generally accepted methylation pathway of inorganic arsenic……………….7 
Structure of the seleno-bis (S-glutathionyl) arsinium ion………………….12 
Figure 2.1 A typical XAS spectrum of a Selenium K-edge.………….…………….18 
Figure 2.2 Schematic illustration of the fluorescence radiation and Auger electron 
emission concomitant with X-ray absorption…………………………..….19 
Figure 2.3 
Figure 3.1 
Plan view of a typical XAS Experimental Setup……………………..…23 
A typical 2mm pin-hole XAS sample cell………………………………….26 
Figure 4.1 Total selenium concentrations in whole blood, red blood cell and plasma 
collected from the rabbit after injection of selenite……..…………………...33 
Figure 4.2 Selenium K near-edge spectra of standard selenium species………..…….35 
Figure 4.3 Least squares fit of the spectrum of rabbit whole blood sample 2hrs after 
injection of selenite to the sum of spectra of standard selenium species......36 
Figure 4.4 Least squares fit of the spectrum of rabbit red blood cells sample 2hrs post 
injection of selenite to the sum of spectra of standard selenium species…39 
xii 
 
Figure 4.5 Least squares fit of the spectrum of rabbit plasma sample 2hrs post injection 
of selenite to the sum of spectra of standard selenium species…………….42 
Figure 4.6 Least squares fit of the spectrum of rabbit cecotrope sample 24hrs post 
injection of selenite to the sum of spectra of standard selenium 
species……………………………………………………………………......45 
Figure 5.1 Total arsenic concentrations (μM) in whole rabbit blood (blue), red blood 
cells (red) and plasma (green) after injection of arsenite only………………49 
Figure 5.2 As K near-edge spectra of standard arsenic species……………………….51 
Figure 5.3 Least squares fit of the As K near-edge spectrum of rabbit whole blood 5min 
post injection of arsenite to the sum of spectra of standard arsenic 
species………………………………………………………………………..52 
Figure 5.4 Least squares fit of the As K near-edge spectrum of red blood cells 5min post 
injection of arsenite to the sum of spectra of standard arsenic 
species…..........................................................................................................55 
Figure 5.5 Least squares fit of the As K near-edge spectrum of plasma 5min post 
injection of arsenite to the sum of spectra of standard arsenic 
species…………..............................................................................................58 
Figure 5.6 Least squares fit of the As K near-edge spectrum of cecotrope 24h post 
injection of  arsenite  to the sum of spectra of  standard arsenic 
species………………………………………………………………..………61 
xiii 
 
Figure 6.1 Total selenium concentrations (μM) in whole blood (blue), red blood cell 
(red) and plasma (green) collected from the rabbit after injection of arsenite 
followed by selenite……………….………………………………………....67 
Figure 6.2 Total arsenic concentrations (μM) in whole blood (blue), red blood cell (red) 
and plasma (green) collected from the rabbit after injection of arsenite 
followed by selenite……………………..………………………………….67 
Figure 6.3 Total selenium concentrations (μM) in whole blood (blue), red blood cell 
(red) and plasma (green) collected from the rabbit after injection of selenite 
followed by selenite………………………………………………………….69 
Figure 6.4 Total arsenic concentrations (μM) in whole blood (blue), red blood cell (red) 
and plasma (green) collected from the rabbit after injection of selenite 
followed by selenite………………………………….………………………69 
Figure 6.5 As K near-edge spectra of standard arsenic species……………………...….71 
Figure 6.6 Selenium K near-edge spectra of standard selenium species………………72 
Figure 6.7 Least squares fit of the As K near-edge spectrum of red blood cell 5min post 
injection of arsenite followed by selenite to the sum of spectra of standard 
arsenic species……………………………………………………………….75 
Figure 6.8 Least squares fit of the spectrum of rabbit red blood cell 5min after injection 
of arsenite followed by selenite to the sum of spectra of standard selenium 
species………………………………….…………………………….......76 
xiv 
 
Figure 6.9 The concentrations of [AsSe(GS)2]- in red blood cell samples vs. time within 
2h post injection of arsenite followed by selenite…………………………...79 
Figure 6.10 Arsenic K near-edge spectra of whole blood, red blood cell and plasma from 
the rabbit 5mins after injection of selenite followed by 
arsenite……………………………………………………………………….81 
Figure 6.11 Selenium K near-edge spectra of whole blood, red blood cell and plasma from 
the rabbit 5mins after injection of selenite followed by 
arsenite….............................................................……………………………82 
Figure 6.12 Least squares fit of the As K-edge spectrum of cecotrope from a rabbit 24 
hours after injection by selenite followed by arsenite…………...........…......88 
Figure 6.13 Least squares fit of the Se K-edge spectrum of cecotrope from a rabbit 24 
hours after injection by selenite followed by arsenite………….....................89 
 
 
 
 
 
 
xv 
 
List of Abbreviations 
α-Se Elemental selenium 
As Arsenic 
As(GS)3 Arsenic triglutathione 
AsO3
3-
 Arsenite 
(CH3)3As=O Trimethylarsine oxide 
CH3As(HlipS2) A sulfur correlated MMA
III
 
Cys-Se-S-Cys Selenodiglutathione 
CysSeSeCys Selenocystine 
DMA Dimethylarsinous acid 
EXAFS Extended X-ray absorption fine structure 
[(GS)2AsSe]‾ Seleno-bis (S-glutathionyl) arsinium ion 
GS-Se-GS Selenodiglutathione 
HlipS2
2-
 The reduced lipoic acid 
HSe
-
 Inorganic selenide 
xvi 
 
MMA Monomethylarsonic acid 
R-Se-R Selenomethionine 
Se Selenium 
SeO4
2-
 Selenate 
SeO3
2-
 Selenite 
SMA S-adenosylmethionine 
XAS X-ray Absorption Spectroscopy 
 
 
 
1 
 
Chapter 1: Introduction 
1.1 Selenium and Arsenic in the environment 
1.1.1 Selenium 
Elemental selenium has several stable allotropes: Gray selenium (polymeric Se), 
black selenium and the deep-red crystalline monoclinic forms, which are composed of 
Se8 molecules, similar to many allotropes of sulfur (Masters, 2009 and House, 2008). 
Selenium is an essential trace mineral nutrient which was first discovered in 1817 
(Berzelius, 1818), and it is normally found in oxidation states (Se
2+
, Se
4+
, Se
6+
). It occurs 
naturally in several inorganic forms such as selenite, selenate and selenide. Major dietary 
sources of selenium include plants, meats and seafood. The levels of selenium in plants 
are related to the levels of selenium in soils (Thavarajah et al, 2007). Food animals that 
eat grains or plants grown in selenium-rich soil have also higher levels of muscle 
selenium.  
Uptake of selenium depends upon the chemical form in which the element is 
present. Studies have shown that the absorption of inorganic forms of selenium such as 
sodium selenite by the gastrointestinal tract may be variable, although generally over 
50%, while organic forms of selenium such as selenomethionine are almost totally 
absorbed (Vendeland et al., 1992). Organic selenium is naturally found in two amino 
acids - selenomethionine and selenocysteine.  Selenomethionine cannot be synthesized by 
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humans, but only by plants or microorganisms (Ruyle, 2009); it has no known 
physiological role and can be considered as a metabolic mistake in which selenium 
substitutes for its fellow chalgonide sulfur by dint of similar chemistry.  Methionine can 
in principal be replaced by selenomethionine in proteins without loss of function 
(Whanger, 2002) and this is commonly exploited by protein crystallographers who use 
selenomethionine substitution to solve structures. Conversely, cysteine cannot be 
similarly replaced by selenocysteine due to the differing chemistries of thiolate and 
selenolate groups. Thus, the pKa values of selenols and thiols are typically 5 and 8, 
respectively, and selenols and selenolates are much more readily oxidized than the 
corresponding sulfur compounds.  
Physiological functions of selenium include regulation of thyroid metabolism and 
Vitamin C redox state. Selenium is also essential for the antioxidant glutathione 
peroxidase enzymes. However, cancer-related possibilities have also been proposed 
(Russo et al., 1997). A number of studies have shown that selenium is positively 
correlated to many beneficial health effects. Selenium helps maintain good skin, healthy 
eyes and eye sight, as well as improving liver function. Researchers in Finland conducted 
a study of serum selenium and cancer in the 1980’s and showed that selenium deficiency 
is correlated with increased risk for certain types of cancer (Männistö et al., 2000). Other 
research has indicated that Vitamin E along with selenium supplement may help prevent 
recurrence of tuberculosis (Villamor et al., 2008).  Additional work has suggested that 
selenium could reduce the risks of developing type II diabetes (Bleys et al., 2007). 
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Scientists have also found that there is a special link between selenium and mercury 
toxicity--selenium helps to remove mercury from body (Cuvin-Aralar ML and Furness 
RW, 1991 and Gailer, et al., 2000), although epidemiological studies are inconclusive in 
linking selenium to protection against the adverse effects of methylmercury (Watanabe, 
2002). A novel arsenic-selenium-glutathione complex has been discovered and it has 
been suggested that selenium supplements might prevent or cure arsenic poisoning 
(Gailer et al., 2000). A geographical correlation between high disease rate of AIDS 
infection and regions of selenium deficient soils and thus low dietary selenium has been 
reported (Baum et al., 1997), and adequate selenium intake may be correlated with 
reduced risk of death in HIV affected patients (Patrick, 1999).  
Selenium deficiency causes Keshan Disease (Tung, 2003), which was first 
observed in China and in other places where selenium levels in soil are very low. Keshan 
Disease can cause heart muscle weakness, cardiomyopathy and higher rates of cancers, 
and the treatment is by dietary selenium supplementation (Chen et al., 1980). The 
recommended amounts are fifty-five micrograms of selenium per day for healthy adult 
men and women, sixty micrograms a day for women during pregnancy and seventy 
micrograms per day for women after pregnancy (Food and nutrition board, 2000). 
Although individuals suffering from Keshan disease receiving selenium supplements do 
not show development of the disease, any damage to the heart muscle which occurred 
before selenium supplementation is not reversed by the treatment.  
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Besides Keshan disease, Kashin-Beck Disease and Myxedematous Endemic 
Cretinism are also related to selenium deficiency (Robert and Utiger, 1998). Kashin-Beck 
Disease is a degenerative osteoarticular disease involving growth and joint cartilage 
osteoarticular disorder that is endemic to certain areas of
 
China, Siberia and North Korea 
(Moreno-Reyes et al., 1998).  Selenium deficiency has also been reported as a possible 
factor to Myxedematous Endemic Cretinism, a form of hypothyroidism which results in 
mental retardation (Goyens et al., 1987).  
Although selenium is an essential trace element, it is toxic in large doses and an 
excess can cause serious health problems. The maximum daily oral dose for adults is 400 
micrograms. Doses exceeding 400 micrograms per day may lead to selenosis (National 
Institutes of Health, 2009). Symptoms of selenium toxicity include hair and tooth loss, 
lesions of the scalp and skin, irritability, nervous system abnormalities, brittle nails and 
liver and kidney problems. 
1.1.2 Arsenic 
Elemental arsenic is a metalloid solid which has no taste and smell.  It was first 
discovered by Albertus Magnus in 1250 when heating realgar (As4S4) and soap together 
(Emsley and John, 2001). Arsenic is found at low concentrations everywhere in nature, 
approximately 5 × 10
−4
 of the Earth's crust, mostly in inorganic form (National Academy 
of Sciences, 1977). It generally occurs at low levels in rocks, soil, water, and air (Gomez-
Caminero et al., 2001). Depending upon environmental conditions, arsenic can exist in 
different valence states, as well in combination with other elements in different forms. 
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Under oxidizing conditions, arsenic usually exist as arsenites (As
3+
) and arsenates (As
5+
). 
These compounds in the human body can be methylated to form monomethylarsonic acid 
(MMA) and dimethylarsinic acid (DMA) (Huerga et al., 2004). In mineralogy, arsenic is 
mostly found bound to sulfur, such as orpiment (As2S3), realgar (As4S4) and arseno-pyrite 
(FeAsS).  
Arsenic and many of its compounds are potentially toxic. The health effects of 
arsenic are different for different chemical forms. In general, inorganic arsenic 
compounds with hard ligands are more toxic than organic arsenic compounds, and 
trivalent form of arsenic is more toxic than pentavalent and elemental forms (Styblo et al., 
2000). In addition, certain organic arsenic compounds, such as arsenobetaine found in 
marine animals, are non-toxic. Arsenic is widely distributed in nature, thus low levels of 
arsenic may be found in a wide range of foods. Fish, seafood, cereals, wine, and cereal 
products are the main dietary source of arsenic. Both organic and inorganic forms of 
arsenic can be found in foods. Although the contents of each are related to the type of 
food, inorganic arsenic is rarely found at high levels.  
Trivalent arsenic is known for its affinity for sulfur, and this is the bioinorganic 
basis of its lethality at high doses. As(III) species such as arsenite kill by respiratory 
poisoning by binding to the essential di-thiol of lipoic acid in enzymes such as pyruvate 
dehydrogenase, the terminal enzyme in glycolysis (Schiller et al., 1977). This is also the 
biochemical basis for the lethal effects of arsenic-based war gases such as Lewisite, 
which is primarily chlorovinyl arsine dichloride. Other trivalent arsenicals such as the 
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mono-functional Adamsite (diphenylaminechlorarsine) are less lethal and have been used 
as riot control agents in the USA, although their mechanism of action is unclear. The 
pentavalent arsenates are toxic too, and also attack the pathways of glycolysis, but instead 
of blocking the pathway by enzyme inhibition they can act as phosphate analogues 
causing uncoupling of oxidative phosphorylation (Crane and Lipman, 1952).  
At sub lethal doses that are less than immediately fatal the metabolism of arsenic is 
important in determining its physiological effects. Many mammalian species can 
methylate inorganic arsenic, but not all. (Vahter, 1994). Variable rates and extent of 
methylation of inorganic arsenic may occur between different species (Hughes, 2002). 
The generally accepted methylation pathway of arsenic is shown in Figure 1.1 (Aposhian 
and Aposhian, 2006). The most possible mechanism is that inorganic arsenic is reduced 
from As(V) to As(III), followed by oxidative methylation to As(V) organic arsenic 
(Thomas et al., 2001). The metabolism of arsenic in liver involves methylation with or 
without enzymes (Vigo and Ellzey, 2006), and is affected by body glutathione, 
methionine levels and choline status (Roy and Saha, 2002). Methylation occurs through 
methyltransferase enzymes involving S-adenosylmethionine (SAM) as a source of the 
methylation. The resulting metabolites monomethylarsonic acid (MMA
III
) and 
dimethylarsinous acid (DMA
III
) are excreted in urine (Aposhian et al., 2000). 
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Figure 1.1 Generally accepted methylation pathway of inorganic arsenic. Modified from ―Arsenic 
Toxicology: Five Questions‖, (Aposhian and Aposhian, 2006). 
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Researchers started to believe that arsenic can have a role in inducing cancers in 
1987 (Hutchinson, 1987). Arsenic has been correlated to different types of cancers, like 
skin cancer, liver cancer, kidney cancer and lung cancer (NTP, 2000). Although there is 
still debate about possible mechanisms of cancer causation, it is widely believed that 
DNA repair inhibition and/or alterations in the status of DNA methylation are involved. 
Increased frequency of sister-chromatid exchanges, micronucleus (Warner et al., 1994 
and Gonsebatt et al., 1997) and chromosomal aberrations are correlated with increased 
arsenic exposure (Mäki-Paakkanen et al., 1998). 
Arsenic is very well known for its poisonous nature at high doses. Its use during 
Victorian times as a homicidal agent gave rise to the term ―inheritance powders‖ which 
were usually arsenic trioxide (As2O3). Despite this infamy there are medical applications 
of the element, some of them are quite valid. During the 20th century, several arsenic 
compounds have been used as pharmaceuticals, for example, arsphenamine is used to 
treat syphilis, Fowler's solution is used to treat skin diseases, and Pearson's Arsenical 
Solution is used for parasitic infestation (Breslow and Cengage, 2002). In 2000, the US 
Food and Drug Administration approved arsenic trioxide (As2O3) – the same compound 
which was the active ingredient in Victorian ―inheritance powders‖ and also known by 
the trade name Trisenox®, for the treatment of patients with acute promyelocytic 
leukemia (Antman, 2001). Arsenic compounds are also used in pigments, wood 
preservation, insecticides, copper and lead alloys, glass and poison gases (e.g., Lewisite) 
as a chemical weapon (Rahman et al., 2004). 
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1.2 Arsenicosis 
Human exposure to arsenic includes occupational exposure and the ingestion of 
contaminated drinking water and seafood. Arsenic absorbed by inhalation and orally, can 
also be excreted in urine. In some areas, arsenic exposure in drinking water is a 
considerable source of daily inorganic arsenic intake (Gomez-Caminero et al., 2001).  
Arsenicosis—chronic arsenic poisoning due to arsenic contamination of 
groundwater—has been recently noted as a serious public health problem in Bangladesh 
(Chaudhuri, 2004) and neighboring countries. Reports have shown that approximately 57 
million people are drinking groundwater with arsenic concentrations greater than the 
World Health Organization’s standard of 10µg/L (Petrusevski et al., 2005). The daily 
intake of total arsenic from food and beverages is generally between 20 and 300µg/day 
(Steiner-Asiedu et al., 2010). The acute lethal dose of arsenic to human beings has been 
estimated to be 0.6 mg/kg/day (Dart, 2004).  
Severe health effects associated with chronic exposure to arsenic include melanosis, 
symmetric hyperkeratosis of palms and soles, depigmentation, Bowen's disease, basal 
cell carcinoma, diabetes, bladder cancer, liver disease and birth defects (Robson et al., 
1963). Residuary arsenic in nails and hair can be detected even years after the exposure. 
In Bangladesh today, there are between 30 to 80 million people who get their drinking 
water from the tube-wells that were installed for the prevention of diarrhea originally. 
These wells were built years ago by international aid agencies to help reduce water-borne 
diseases and give local people a clear source of water instead of using the dirty, disease 
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infested ground water. It is estimated about 130 million people which is 90% of the 
population in Bangladesh prefer to drink well water (WHO, 2001). Only a bit greater 
than 10% of the Bangladeshi people who live in the large agglomerations and some 
district towns have access to the piped water supplies (WHO, 2001).   
It is now generally accepted that geological origin causes the groundwater in 
Bangladesh being contaminated by arsenic. Scientists found that the well drilled in 
Bangladesh with the highest arsenic concentration has been there for many years, when 
arsenic has been released from the sediments and infiltrated to underground from the 
surface after microbial metabolism. Arsenic present in drinking water in Bangladesh is 
mainly As(III) with lower levels of As(V), with a ratio of 9:1 (Spallholz et al,. 2006). 
Scientists have adopted several physical-chemical treatment methods to remove arsenic 
from drinking water, such as adsorption-co-precipitation using iron and aluminum salts 
and ion exchange (Mortoza, 1997). But these treatments are neither applicable to a mass 
of tube wells nor highly effective. Chelation therapy may help relieve some of the 
symptoms and improve clinical manifestations.  However, the damage in several organs 
due to chronic arsenicosis is irreversible and there is no effective therapy for these 
diseases (Guha Mazumder, 2008). It is obvious that scientists and researchers should find 
an important and effective method to prevent and treat arsenicosis. 
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1.3 Antagonism between Arsenic and Selenium 
Arsenic and Selenium have similar chemical properties, but their biological effects 
are very different (Zeng et al., 2005). Therefore, the interaction between arsenic and 
selenium depends on their different chemical forms. In general, arsenite and selenite are 
the most common oxy-ion of arsenic and selenium in the environment, respectively. 
When arsenite and selenite are administered separately, they are toxic, but when these 
two compounds are given together, the toxicity is cancelled. The antagonism between 
arsenic and selenium was first discovered in the 1930’s (Moxon, 1938).  Evidence has 
shown that arsenic compounds can protect against a variety of different forms of 
selenium (Levander, 1977). It is reported that sodium arsenite, can not only active against 
sodium selenite, but also selenocystine (Du Bios et al., 1940). Experimental results have 
also suggested that arsenite can fight the toxicity of selenite in different animal species 
(e.g. dog, swine, and cattle) (Levander, 1977). Although the antagonism between arsenic 
and selenium has been reported since 1938, the mechanism still remains unclear.  
In 2000, the molecular basis of the in vivo antagonism between arsenite and selenite 
was discovered. The formation of a novel arsenic-selenium compound: seleno-bis (S-
glutathionyl) arsinium ion, [(GS)2AsSe]‾ (Figure 1.2), which is subsequently excreted in 
rabbit bile was demonstrated (Gailer et al., 2000). The details of the arsenic-selenium-
glutathione complex were elucidated using X-ray absorption spectroscopy. 
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Figure 1.2: Structure of the seleno-bis (S-glutathionyl) arsinium ion, which is abbreviated 
[(GS)2AsSe]‾. 
13 
 
In earlier work, a New Zealand white rabbit was used as animal model to determine 
the molecular basis of the antagonism of arsenite and selenite. After the simultaneous 
administration of environmentally relevant doses of arsenite and selenite, [(GS)2AsSe]‾ 
was excreted from the bile of the rabbit (Gailer et al., 2004). This evidence suggests that 
the in vivo formation of this metabolite comprises an important mechanism of toxicology. 
The chemical reaction of this mechanism has been predicted as the following chemical 
equation:   
 sA(OH)3 + HSeO3 ‾ + 8GSH →   [(GS)2AsSe]‾ + 3GSSG +6H2O   [1] 
According to equation [1], 1 mole of arsenite and 1 mole of selenite with 8 mole 
equivalents of glutathione forms [(GS)2AsSe]‾ (Gailer et al., 2000). Consequently, it is 
important to have high concentrations of glutathione to form [(GS)2AsSe]‾ from arsenite 
and selenite in vivo of mammals.  
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1.4 Hypothesis and Objectives 
1.4.1 Hypothesis 
Because biliary excretion of [(GS)2AsSe]
-
 would unavoidably consume the body 
load of selenium then insufficient dietary intake of selenium might cause of selenium 
deficiency. Furthermore, the symptoms of selenium deficiency are very similar to those 
of Bangladeshi people who are suffering long term chronic low-level arsenic poisoning. 
Accordingly, our research group has hypothesized that those patients who experienced 
arsenicosis in Bangladesh are in fact suffering a selenium deficiency. We propose the 
following experiments to further understand the formation and elimination of 
[(GS)2AsSe]
-
, and to build a scientific basis for treatment of arsenicosis. The hypothesis 
to be tested in the work presented in this thesis is that the in vivo chemistry of arsenic and 
selenium can be monitored using X-ray absorption spectroscopy of blood samples, and 
that this can be used to develop an understanding of the formation and elimination of 
[(GS)2AsSe]
-
. Using rabbit as our animal model, we expect that the speciation results of 
arsenic in blood will be different when administering arsenite alone or with selenite 
simultaneously. We propose that [(GS)2AsSe]
- 
can be detected in blood samples very 
rapidly after injection of arsenite and selenite, and will be eliminated from blood stream 
after a certain period of time post injection. In addition, [(GS)2AsSe]
- 
might be found in 
cecotrope samples after injection of both arsenite and selenite. The experiments proposed 
in this thesis will also lead us to the answer of whether [(GS)2AsSe]
- 
is assembled in red 
blood cells or plasma in vivo.  
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1.4.2 Objectives 
Experiments described in this thesis are trying to answer the following questions: 
1. How fast does [(GS)2AsSe]
-
 form? 
Rabbits will be injected either with arsenite, selenite or both, and samples of whole 
blood will be taken at a series of times. Both As and Se K-edge spectra will be 
recorded, and this will give information on how fast [(GS)2AsSe]
-
 forms. 
 
2. How fast is [(GS)2AsSe]
-
excreted? 
Blood samples will also be collected at chosen times and As and Se K-edge spectra 
will be recorded to see how fast [(GS)2AsSe]
-
 is eliminated from blood. 
 
3. What is the speciation of arsenic and selenium in blood and cecotrope? 
Blood and cecotrope samples will be also collected at chosen times and As and Se 
K-edge spectra will be recorded to analyze the speciation of arsenic and selenium.  
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Chapter2: Experimental Technique 
2.1 X-Ray Absorption Spectroscopy 
 X-ray Absorption Spectroscopy (XAS) is an experimental technique which can be 
widely used to determine the physical and electronic structure of matter. XAS is element 
specific and can provide chemical speciation information of metals and metalloids 
(Schulze and Bertsch, 1995). X-rays have a wide range of wavelengths, and these highly 
energetic photons are used to measure the molecular structure of samples. One of the 
main methods of analyzing the atomic level of new materials is X-ray crystallography. 
However, in order to use this method, the new material must be crystallized first. But no 
pre-treatment of digestion, drying or extraction is required for XAS to test metal or 
metalloid materials (George et al., 2007). XAS can also yield limited molecular structural 
information of amorphous samples and it can probe solid, liquid, gas or even mixture 
samples. 
A typical X-ray absorption spectrum at the selenium K-edge is shown in Figure 2.1. 
XAS is divided into different regions—pre-edge, near-edge and extended X-ray 
absorption fine structure (EXAFS). The region before the edge rise is called the pre-edge 
region, where the X-rays have insufficient energy to eject a core-electron. At a well-
defined X-ray photon energy, a sharp rise in absorption coefficient is observed which 
corresponds to the transition of the core electrons to continuum. The X-ray absorption 
near-edge structure is extended in the first 30-40eV past the absorption edge where X-ray 
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photons has just enough energy to eject a core-electron. Near-edge features can provide 
important information of electronic structure and near-edge spectra are sensitive to 
oxidation state, nature of ligands and coordination geometry (Van Elp et al., 1995).  Near 
edge spectra of each forms of an element is often highly distinct, and can therefore be 
used to identify unknown chemical species by a simple comparison with spectra of 
known standard compounds.  There is an increasingly use of near-edge spectra to 
analysis chemical speciation in complex and mixtures, such as sediments, soil and 
organisms in environmental sciences as well as tissue samples in life and health sciences 
(George, 2010). 
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Figure 2.1 A typical XAS spectrum of a Selenium K-edge. 
Upper figure shows the full spectrum of the pre-edge, edge, and extended X-ray 
absorption fine structure (EXAFS) regions. Lower figure shows an expanded view of the 
near edge region. 
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 EXAFS was observed early in the 20’th century by Kronig. The exact origin of the 
structure was unclear until the 1970’s when Sayers, Stern and Lytle were finally able to 
explain the nature of EXAFS and proved how EXAFS can be used as quantitative 
structural probe (Sayers et al., 1979). Understanding the origins of the EXAFS allows 
estimation of the distance between absorber atom and backscatterer atom, as well as 
approximation of numbers of electrons around backscatterer since more electrons provide 
more effective backscatterer.  From EXAFS, it is possible to determine the number of a 
particular type of backscatterer at a particular distance. 
     
 
 
Figure 2.2 Schematic illustrations of the fluorescence radiation and Auger electron 
emission concomitant with X-ray absorption. 
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X-ray absorption occurs due to core electrons absorbing the X-ray and being 
ejected from the atom as photoelectrons.  As shown in Figure 2.2, the absorption of an X-
ray photon creates a core hole, which can be filled by decay of an out electron via 
different mechanisms.   
First, the core hole could be filled concomitantly with X-ray fluorescence emission.  
This occurs when the outer electron releases its extra energy by emitting X-ray 
fluorescence while it decays from an outer line to fill the core hole. The energy difference 
between the outer and inner electrons is the same as the fluorescence photon energy. 
Absorption by different core levels gives rise to different X-ray absorption edges. For 
example, at lower energies, ejection of 3d electrons gives rise to the MV,IV absorption 
edges. At higher X-ray energies, ejection of 1s electrons gives rise to the K absorption 
edge.   
The core hole created by X-ray absorption may be filled by the decay of an outer 
electron, with a concomitant emission of an Auger electron (George et al., 2007). The 
kinetic energy of the Auger electron is the energy difference between the initial and final 
state of the atom (Teo et al., 1986). 
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2.2 Synchrotron Radiation 
A tunable X-ray source is required to generate X-rays and measure the energy-
dependent absorption coefficient of a material. A synchrotron light source generates a 
high-intensity, tunable source of X-rays. An electron gun fires bunches of electrons 
through tubes into the booster ring (CLS, 2010). Microwave energy is then used to 
accelerate the electrons up to nearly the speed of light (Elder et al., 1947).  The electron 
beam is then ejected into synchrotron storage ring, where these high-speed high-energy 
electrons are bent by magnets inside the storage ring, or by the insertion devices such as 
wigglers and undulators.  Wigglers and undulators are insertion devices in a synchrotron 
where the electron beam would normally go straight. A wiggler is the high-field case 
while an undulator is the low-field case.  
In general, different optical elements are used in a synchrotron to generate a beam 
which has a broad distribution both in energy and space.   In synchrotron facilities, a 
beamline is the instrumentation that carries beams of synchrotron radiation to an 
experimental end station. Figure 2.3, (A) shows a plan view of components for a modern 
X-ray beamline for XAS.  At the front end are the X-ray optics, and the experimental 
station is at the end. The front end houses wiggler, safety value and photon shutters. X-
ray optical component includes collimation mirror, monochromator and focusing toroid.  
A monochromator is the principal optical device that we use to select a narrow 
band of wavelengths of light from a wider range of energies. A double crystal 
monochromator allows the diffracting beam to be parallel with the incident beam. 
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Monochromator crystal material must have excellent stability to X-rays, thermal loading, 
crystal perfection and narrow rocking curve (Kudo, 1965). Silicon is the most widely 
used material. In a typical XAS beamline, the first mirror collimates the beam through 
monochromator and the second mirror is used to focus the beam horizontally and 
vertically on the sample. Both mirrors can be used for harmonic rejection by choosing 
mirror material and tilt angle so that fundamental energy is reflected, and harmonic 
energy is absorbed. 
Figure 2.3 (B) shows a plan view of a typical XAS experimental setup. A liquid 
helium cryostat is used to cool the sample to reduce radiation damage and make EXAFS 
more intense because of freezing out of atomic vibrations (George et al., 2007). A 
fluorescence detector is used to detect the fluorescence accompanying the X-ray 
absorption process. Typically a solid state germanium array detector or a fluorescent ion 
chamber detector is used, depending on the different concentration ranges. The sample is 
set at 45 degree to the beam and the fluorescence detector is set at 90 degree to the beam 
and 45 degree faces to the sample plane. This will help to reduce the intervention of 
Compton scattering. A standard foil of the element of interest is used for energy 
calibration. 
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Figure 2.3 (A) Schematic optical component layout of a typical X-ray beamline for XAS 
                  (B) Plan view of a typical XAS fluorescence experiment setup 
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Chapter 3: Materials and Methods  
3.1 Animal Model and treatment   
3.1.1 Animal Model 
Rabbits were chosen as an animal model in preference to rat and mouse because 
rabbit hemoglobin is a better model of human hemoglobin. In particular, rat and mouse 
hemoglobin includes cysteine residues which can interact with arsenic species (Lu et al., 
2004; Petric et al., 2000; Carter et al., 2003). These thiols are not present in either rabbit 
or human. Thus, arsenic binding to rat hemoglobin can be 3-16 fold greater than human 
hemoglobin (Aposhian, 2006), and consequently rat does not provide a good model for 
arsenic metabolic research. Instead, rabbit and hamster turn out to be more reasonable 
models (Aposhian, 2006). In order to facilitate collection of blood samples, rabbits were 
chosen as the animal model in our experiments.  
Male New Zealand white rabbits (1.5-2kg) were purchased from Charles River 
Laboratories International (Wilmington, MA, USA) and maintained for 1 week before 
experiments on a ―high fiber‖ rabbit diet at the Laboratory Animal Services Unit, College 
of Medicine, in University of Saskatchewan. Each rabbit was kept in separate cage and 
was taken care of by animal care professionals. All animal studies conduct in this thesis 
received approval from the institutional animal research ethics board for the experimental 
use of the rabbits.  
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3.1.2 Treatment 
For each rabbit studied, vein catheters were placed. Rabbits were placed in a cat 
bag, and the hair over the artery was removed by shaving with a straight razor blade. An 
IV extension set was flushed with sterile saline and the syringe was left on the end of the 
extension set. Oil of wintergreen was applied with the cotton-tipped applicator to the skin 
over the artery to dilate the vein, and a 22 G catheter was then inserted into the vein. The 
IV extension set was then attached to the catheter which was flushed with 0.5 ml Saline, 
the IV extension was then locked and the saline syringe removed. The catheter was then 
glued to the ear with tissue glue and the extension set secured to the ear with surgical 
adhesive tape.  
Following preparation of the rabbits the test compounds were injected. Arsenite 
(0.30 mg As/kg of body weight) or selenite (0.32 mg Se/kg of body weight) were 
dissolved in 20mM PBS (phosphate buffered saline) and adjusted to pH=7.4. Depending 
on the body weight of each rabbit, 1.5-2ml 0.30mg/ml arsenite or 0.32mg/ml selenite 
solution were injected to the rabbit, and when administering both chemicals, there was a 
3-min interval in between doses. The dose of arsenite or selenite was chosen so as to be 
approximately one quarter of the LD50 for rabbit. Four rabbits were investigated using 
different treatments. The first was given selenite solution only (dose as above). The 
second rabbit was given arsenite solution only (dose as above). The third rabbit was 
treated with arsenite first and then 3min later followed with selenite solution. The fourth 
rabbit was treated with selenite first and then followed with arsenite 3min later. 
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3.2 Sample Preparation 
3.2.1 Blood Sampling 
3ml of whole blood samples were collected and mixed with heparin from each 
animal via the auricular vein catheter at the following time intervals post injection (after 
second dose when both were injected): 5 min, 20 min, 40 min, 60min, 2hr, 4hr and 24hr. 
Rabbits were conscious during all procedures. Blood samples before injection of test 
compounds were also collected as a control. Plasma and red blood cell samples were 
centrifuged and separated from whole blood samples collected at each time interval. At 
each time point, sample was immediately placed in 2mm sample cells (Figure 3.1) and 
frozen in liquid nitrogen for XAS analysis. Liquid nitrogen exists as liquid between 63K 
and 77.2K (-346°F and -320.44°F), samples kept in Dewars filled with liquid nitrogen 
were stable. 
 
Figure 3.1 A typical 2mm pin-hole XAS sample cell. 
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3.2.2 Cecotrope Sample Preparation 
Cecotrope are produced at night and ingested by the rabbit and so re-enter the 
gastrointenstinal tract. Rabbits eat cecotropes to get essential nutrients (Hirofumi, 2001). 
In order to stop rabbits from eating their cecotropes, a collar was put around the neck of 
the rabbit after injection of test compounds. After injection of 24hrs, cecotrope samples 
were collected and collar was removed from the rabbit. Cecotrope samples were ground 
and packed in 2mm sample cells and immediately frozen in liquid nitrogen for XAS 
analysis. 
After collecting all the blood and cecotrope samples, rabbits were euthanized by 
injection of Phenobarbital. 
 
 
 
 
 
 
28 
 
3.3 Data Collection and analysis  
3.3.1 Data Collection 
All data present in this thesis were collected at Canadian Light Source (CLS) on the 
hard X-ray Micro-Analysis (HXMA) beamline as well as on Structural Molecular Bio-
XAS beamlines 7-3 and 9-3 at Stanford Synchrotron Radiation Laboratory (SSRL). CLS 
is a third-generation synchrotron facility with a 2.9GeV storage ring and a 250mA ring 
current. SSRL has a SPEAR storage ring containing 250mA at 3.0GeV. At all beamlines, 
samples are maintained approximately at 10K in a liquid helium flow cryostat.  The 
Arsenic and Selenium K-edge spectra are recorded.  At both HXMA and 9-3 beamlines, 
there are an upstream collimating mirror, a Si (220) double-crystal monochromator and a 
downstream focusing mirror. The incident X-ray intensity is monitored using N
2 
filled 
ionization chamber. Near-edge spectra are recorded by monitoring the K
α 
fluorescence 
using a 30-element germanium detector. 
The energy is calibrated with reference to the lowest energy inflection point of the 
elemental foil (α-arsenic or hexagonal selenium), which are assumed to be 11867.0eV 
and 12658.0eV.  
3.3.2 Data Analysis 
Background subtraction, normalization and edge fitting were carried out according 
to standard methods using the EXAFSPAK program in this thesis. EXAFSPAK is a suite 
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of computer programs for analysis of X-ray Absorption Spectra written by Dr. Graham 
George and Dr. Ingrid Pickering (George et al., 2000).  
The raw data file contains all channels of the detector from one single scan. Before 
analyzing data, every scan of data should be investigated by eye for quality and 
consistency. Individual sweep can be excluded if there are any bad channels. The 
spectrum of a mixture of more than one chemical form of an element appears as the sum 
of the spectra of the individual components. The height of the edge jump of each 
component is proportional to the quantity of the element in that form. The spectrum is 
normalized so that the edge jump is unity. With normalized spectra, the height of the 
edge jump of each component is proportional to the fraction of the element present in that 
form. Near edge fitting are carried out by Least-square DATFIT program in EXAFSPAK. 
In DATFIT program, a library file is created which contains the spectra of the 
standard compounds that were selected to be used in the fit. Data were then compared 
with the standard compounds. In Least-square fitting, equation (1) and (2) are used to 
calculate the fraction of each component. The program of DATFIT gives us e.s.d., 
residual, total and the plotting after the fit. E.s.d. means the estimated standard deviation 
derived from the diagonal elements of variance-covariance matrix (George et al., 2000). 
In general, three times of the e.s.d. is quoted, which stands for the 99% confidence limit. 
The average sum of squares of the differences between calculated and observed 
normalized intensities is residual. As a given unknown spectrum, the smaller the residual 
the better the fit is. Total is the sum of the fractions of each component, which ideally 
should add up to one. From eye inspection of the plotting of the residual, noise or 
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substantial features can be depleted. Also, thought must be given to determine if the 
components from the fitting are chemically reasonable for the sample. Once e.s.d, 
residual and chemical seems reasonable, the results can be finalized. All standard spectra 
of selenium and arsenic compounds in this thesis were collected at CLS on beamline 
HXMA and beamline 9-3 at SSRL. 
  
 
F – Function being minimized by non-linear regression  
y j,obs  – Observed intensity of mixture spectrum at energy j 
y j,calc – Intensity of calculated spectrum at energy j 
j  – Energy point number 
N – Total number of energy points 
I  – Component number 
m – Number of components 
Ii,j – Normalized intensity of spectrum of component i at energy j 
xi – Proportion (fraction) of element as component i 
 
 
Equation (1) 
Equation (2) 
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3.3.3 Preparation of  Standards 
The height of the edge jump of each near-edge spectrum is proportional to the 
concentration of the examined element in the sample. Therefore, the concentration of 
each element in the unknown samples can be obtained by comparing the edge jump to the 
standard of known concentration.  Standard solutions of 0.1mM arsenite and selenite 
were prepared fresh each time before data collection on the beamline. The near-edge 
spectra of the standard arsenite and selenite were recorded under the same conditions as 
the blood samples.  The edge jumps of the standard arsenite and selenite were analyzed in 
the same manner as the experimental blood samples using EXAFSPAK.  
Selenium and arsenic K near-edge standard spectra of different selenium species 
(e.g. selenite, selenate, [(GS)2AsSe]‾, selenocystine, etc.) and arsenic species (arsenite, 
arsenate, [(GS)2AsSe]‾, arsenic triglutathione, etc.) which possibly present in the samples 
were collected on the beamline . These standard spectra from the standard compounds 
were used to determine what species were present in our unknown samples. 
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Chapter 4: Disposition of Selenium after Injection of 
Selenite  
Male New Zealand white rabbits (1.5-2kg) were selected for studying the fate of 
selenium after injection within a mammalian system.  Selenite was injected via the ear 
vein as described in Chapter 3. Blood and cecotrope samples were collected after 
injection at different time intervals as described in Chapter 3. 
4.1 Total Selenium Concentration in Blood after Injection of Selenite  
Total concentrations of selenium in rabbit blood after injection of selenite were 
measured by comparing the edge jump of selenium K near-edge spectra to the standards 
of known concentration. Figure 4.1 shows the selenium concentration in whole blood 
(blue), red blood cell (red) and plasma (green) as well as the bars indicate data ± error. 
Errors were estimated using the signal amplitude, defined as the edge jump, and noise 
were determined by measuring the amplitude of the noise above the edge. While this is 
not a rigorous statistical treatment it gives a reasonable approximation of the uncertainty 
of the concentration estimates.  There was little selenium present at time point 0 which 
was just before selenite injection, and that selenium probably came from the naturally 
present in the diet at a level of about 2.2 µM.  Samples of whole blood, red blood cell and 
plasma 24hr after injection of selenite were also collected, but the concentrations were 
found to be very low.  The selenium levels in plasma, whole blood and red cell were all 
very similar, and while there may be slightly more selenium in plasma, this difference 
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was close to our estimated error. The sample taken at 5min after injection showed the 
highest concentration of selenium in blood, and thereafter the concentrations of selenium 
gradually decreased, until 24hr after injection of selenite, selenium reached a level of 
about 3.5 µM. 
 
Figure 4.1 Total selenium concentrations (µM) in whole blood (blue), red blood cell (red) 
and plasma (green) collected from the rabbit after injection of selenite only, bars indicate 
data ± error; data were collected before injection, and at 5min, 20min, 40min, 1hr and 2hr 
after injection of selenite, respectively.  
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4.2 Speciation of Selenium in Blood after Injection of Selenite                      
Selenium K near-edge X-ray Absorption spectra of whole blood, plasma and red 
blood cell samples after injection of selenite were collected on the HXMA beamline at 
CLS. The selenium K near-edge spectra are sensitive to the local electronic environment 
of the selenium and oxidation states and thus can be used to identify the chemical forms 
of selenium present in each sample. In this study, selenate (SeO4
2-
), selenite (SeO3
2-
), 
elemental selenium (α-Se), selenomethionine (R-Se-R), selenodiglutathione (GS-Se-GS), 
selenyl sulfide (Cys-Se-S-Cys), selenocystine (CysSeSeCys) and inorganic selenide 
(HSe
-
) were used to represent the selenium environments, respectively (Figure 4.2). 
Other selenium species were considered as potential models but the analysis showed 
insignificant fractions in all blood samples.  
Least squares fit of the Se near-edge spectrum from whole blood 2h post injection 
to the sum of spectra of the standard model species are shown in Figure 4.3. Whole blood 
samples from other time points were fitted using the same standard species; a summary 
of the speciation results is shown in Table 4.1. Before injection of selenite, only two 
components—selenide and selenocystine were identified in whole blood sample. After 
injection of selenite, three components appeared to yield the best fits —selenide, selenite 
and elemental selenium. Elemental selenium (α-Se) was found to be the most abundant of 
all selenium compounds examined after injection, with a fraction varying from 60% to 
51%.  It is also possible that an unknown selenium species which has a similar spectrum 
to elemental selenium exists and this unknown species has a greater fraction of total 
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selenium in blood after injection of selenite. Among the samples collected from 5mins to 
2hrs post injection, the fraction of selenite was quite stable; slightly fluctuate at 10%±1% 
of the total selenium content. However, the fraction of selenide was observed to increase 
over time and the fraction of elemental selenium decreases within 2h post injection of 
selenite.  
                     
Figure 4.2 Selenium K near-edge spectra of standard selenium species.  
SeO4
2-
 (selenate), SeO3
2- 
(selenite), α-Se(elemental selenium), R-Se-R (selenomethionine), 
GS-Se-GS (selenodiglutathione), CysSeSeCys (selenocystine), Cys-Se-S-Cys (selenyl 
sulfide) and HSe
-
 (selenide), respectively. 
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Figure 4.3 Least squares fit of the spectrum of rabbit whole blood sample 2hr after 
injection of selenite to the sum of spectra of standard selenium species. Figure shows the 
whole blood data (dotted line), the fit (solid line) and the individual components, scaled 
according to their contributions to the fit: a. α-Se b. HSe- c. SeO3
2-
. The residual is shown 
offset below. Numerical results are shown in Table 4.1. 
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Table 4.1 Percentage of selenium as each selenium species in rabbit whole blood 
samples after injection of selenite.    
Time HSe
-
 SeO3
2-
 α-Se CysSeSeCys CysSeSCyS 
0 47(7) — — 53(7)  —* 
5min 28(5) 11(2) 60(3) — — 
20min 31(5) 11(3) 58(3) — — 
40min 32(5) 11(3) 57(3) — — 
1hr 36(6) 9(3) 55(3) — — 
2hr 41(4) 9(2) 51(2) — — 
  
Se K near-edge fitting results from whole blood from the rabbit injected with selenite, 
samples represent whole blood collected before injection, 5min, 20min, 40min, 1h and 2h 
post injection of selenite, respectively. Values derived from percentage contributions of 
spectra of standards to the best fit of the sample spectra. Figures in parenthesis show 
three times estimated standard deviation. Selenide, selenite, elemental selenium and 
selenocystine are represented by HSe
-
, SeO3
2-
, α-Se and CysSeSeCys, respectively. 
 
* Note that this component was observed in plasma. Presumably it is not observed here 
because of the higher relative errors and correlation with CySSeSeCyS in the fit.  
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The Se K near-edge spectra of the red blood cell fractions after injection of selenite 
within 2h were also collected. Least squares fit of the red blood cell spectrum 2h post 
injection of selenite to the sum of spectra of standard species is shown in Figure 4.4. The 
remaining time points for the red blood cell fractions were fitted in the same manner, the 
results of which are shown in Table 4.2. 
  Before injection of selenite, two components were found to obtain the best fit 
(selenide and selenocystine) in red blood cell. After injection of selenite, three 
components (selenide, selenite and elemental selenium) appeared to obtain the best fits in 
red blood cells. Elemental selenium and selenide were found to be the most abundant of 
all selenium species. At 5min time point, the red blood cell had the highest fraction of 
elemental selenium and the least fraction of selenide. Among all the samples collected 
within 2hrs post injection, the fraction of selenite was quite stable, slightly fluctuating 
around 8%±2% of the total selenium content.         
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Figure 4.4 Least squares fit of the spectrum of rabbit red blood cells sample 2hr post 
injection of selenite to the sum of spectra of standard selenium species. Figure shows the 
whole blood data (dotted line), the fit to the data (solid line) and the individual 
components, scaled according to their contributions to the fit: a. α-Se b. HSe- c. SeO3
2-
. 
The residual is shown offset below. Numerical results are shown in Table 4.2. 
 
 
 
 
 
40 
 
Table 4.2 Percentage of selenium as each selenium species in rabbit red blood cell 
samples after injection of selenite.    
Sample HSe
-
 SeO3
2-
 α-Se CysSeSeCys 
0 46(6) — — 54(7) 
5min 30(3) 9(1) 61(2) — 
20min 46(4) 8(2) 46(2) — 
40min 40(4) 10(2) 50(2) — 
1hr 45(4) 7(2) 47(2) — 
2hr 53(5) 7(3) 41(3) — 
  
Se K near-edge fitting results from whole blood from the rabbit injected with selenite, 
samples represents red blood cell collected before injection, 5min, 20min, 40min, 1h and 
2h post injection of selenite, respectively. Values derived from percentage contributions 
of spectra of standards to the best fit of the sample spectra. Figures in parenthesis show 
three times estimated standard deviation. Selenide, selenite, elemental selenium and 
selenocystine are represented by HSe
-
, SeO3
2-
, α-Se and CysSeSeCys, respectively. 
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The Se K near-edge spectra of the plasma fractions after injection of selenite within 
2h were also collected. Least squares fit of the plasma spectrum 2h post injection of 
selenite to the sum of spectra of standard species is shown in Figure 4.5. The remaining 
time points for the plasma fractions were fitted in the same manner; the results of which 
are shown in Table 4.3. 
Before injection of selenite, three components were found to obtain the best fit 
(selenite, selenocystine and selenyl sulfide) in plasma. After injection of selenite, two 
components (selenite and elemental selenium) appeared to yield the best fits in plasma. 
At 5min time point, plasma had highest fraction of elemental selenium (79%) and the 
lowest fraction of selenide (21%). From 20min to 2hr post injection of selenite, the 
fractions of elemental selenium in plasma decreased and stabilized at around 77%±1% of 
the total selenium content.  Meanwhile, the fractions of selenide increased and stabilized 
at around 23%±1% of total selenium. Inorganic selenide was not expected to be found in 
plasma, because plasma is an oxidizing environment. (Schafer and Buettner, 2001; Ingrid 
et al., 1998). 
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Figure 4.5 Least squares fit of the spectrum of rabbit plasma sample 2hr post injection of 
selenite to the sum of spectra of standard selenium species. Figure shows the plasma data 
(dotted line), the fit to the data (solid line) and the individual components, scaled 
according to their contributions to the fit: a. Se
0
 b.SeO3
2-
. The residual is shown offset 
below. Numerical results are shown in Table 4.3. 
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Table 4.3 Percentage of selenium as each selenium species in rabbit plasma 
samples after injection of selenite.    
Sample SeO3
2-
 α-Se CysSeSeCys CysSeSCys 
0 24(2) — 49(19) 27(18) 
5min 21(1) 79(2) — — 
20min 24(1) 76(2) — — 
40min 23(1) 77(2) — — 
1hr 24(1) 76(2) — — 
2hr 23(1) 77(2) — — 
  
Se K near-edge fitting results from whole blood from the rabbit injected with selenite, 
samples represents plasma collected before injection, 5min, 20min, 40min, 1h and 2h 
post injection of selenite, respectively. Values derived from percentage contributions of 
spectra of standards to the best fit of the sample spectra. Figures in parenthesis show 
three times estimated standard deviation. Selenite, elemental selenium selenocystine, 
selenyl sulfide are represented by SeO3
2-
,
 α-Se, CysSeSeCys and Cys-Se-S-Cys, 
respectively. 
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4.3 Speciation of Selenium in Cecotrope after Injection of Selenite  
The Se K-near edge spectra of rabbit cecotrope sample 24hr post injection of 
selenite was also collected.  Spectrum of cecotrope was fitted to the sum of spectra of 
standard selenium species (Figure 4.6), five components (selenodiglutathione, selenide, 
selenite, selenate and selenomethionine) appeared to yield the best fit to data. A species 
resembling GS-Se-GS was found to be the most abundant species comprising 54% of 
total selenium content in cecotrope. Organic selenide (R-Se-R) was present in smaller 
amount with a fraction of 22% of total selenium, and inorganic selenide was present at a 
fraction of 19% of total selenium. In addition, inorganic selenide (HSe
-
) was found in 
cecotrope, this is probably because cecotrope is a product from cecum, and cecum is an 
anaerobic environment so that HSe
- 
can exist. 
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Figure 4.6 Least squares fit of the spectrum of rabbit cecotrope sample 24hr post 
injection of selenite to the sum of spectra of standard selenium species. Figure shows the 
cecotrope data (dotted line), the fit (solid line) and the individual components, scaled 
according to their contributions to the fit: a. GS-Se-GS (selenodiglutathione) b. HSe
-
 
(selenide) c. SeO3
2-
 (selenite), d. R-Se-R (selenomethionine), e. SeO4
2- (Selenate). The 
residual is shown offset below.  
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4.4 Discussion 
The above results show that after injection of selenite into rabbit, blood selenium 
levels in plasma, red cell and whole blood were all very similar. After injection of 
selenite, HSe
-
 and α-Se were found to be the most abundant selenium species in red blood 
cells and whole blood samples within 2h post injection. It was reported that nano-
particulate elemental selenium can be formed by the reaction of selenite and glutathione 
(JS Zhang et al., 2001). It was also believed that nano-size elemental selenium had a 
lower toxicity than selenite. In vitro studies had shown that the detoxification of selenite 
involves reactions with thiol-containing molecules like glutathione, directing the 
production of intermediate metabolites hydrogen selenide (HSe
-
) and finally to elemental 
selenium (H.E. Ganther, 1968 and J.L. Kice, 1980). However, the mechanism of how 
elemental Se was formed in blood remains unknown. Our experimental results 
demonstrate that elemental selenium α-Se is rapidly formed in rabbit blood after injection 
of selenite. It is widely known that there are selenoproteins in plasma and selenoprotein P 
is the most abundant. It includes 10 selenocysteine residues (Se-Cys). Recently, 
researchers have found that selenoprotein P plays important roles in selenium 
homeostasis and transport in mammals (Burk et al., 2009). In our experiments for time 
zero (before injection of selenite), the selenium in plasma was likely to be predominantly 
selenoprotein P. Thus, the observation of Cys-S-Se-Cys suggested that this form is 
predominant in selenoprotein P and in other selenoproteins. Our observation of selenite in 
47 
 
plasma is also consistent with prior work as a Japanese group has indicated that free 
selenite is normally present in plasma (Suzuki and Itoh, 1996). 
24hr post injection of selenite, a small fraction of selenite was detected in cecotrope 
sample. This indicates the selenite injected to the rabbit has largely been removed from 
blood. After digestion and metabolism, selenomethionine and selenodiglutathione were 
found to be the most abundant species in cecotrope.   
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Chapter 5:  
Disposition of Arsenic after injection of Arsenite 
Male New Zealand white rabbits (1.5-2kg) were selected for studying the fate of 
arsenic after injection within a mammalian system. Arenite was injected to the rabbit as 
described in Chapter 3. Blood and cecotrope samples were collected after injection at 
different time intervals as described in Chapter 3. 
5.1 Total arsenic concentration in blood after injection of arsenite 
Total concentrations of arsenic in rabbit blood after injection of arsenite were 
measured by comparing the edge jump of arsenic K near-edge spectra to standards of 
known concentration. Figure 5.1 shows the total arsenic concentration in whole blood 
(blue), red blood cell (red) and plasma (green) as well as the bars indicating data ± error. 
Errors were estimated using the signal amplitude, defined as the edge jump, and noise 
determined by measuring the amplitude of the noise above the edge. While this is not a 
rigorous statistical treatment it gives a reasonable approximation of the uncertainty of the 
concentration estimates. Time 0 stands for total arsenic concentration before injection. 
From figure 5.1, there was no measureable arsenic in rabbit blood samples before 
injection. Samples of whole blood, red blood cell and plasma 4h and 24h after injection 
of arsenite were also collected. The concentration of arsenic in blood sample 4h after 
injection was as low as 0.2±0.05µM, while the total concentration of arsenic in blood 24h 
post injection was 0.  At each time point in Figure 5.1, more arsenic was observed in red 
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blood cell fraction compared with whole blood or plasma. The highest concentration of 
arsenic in blood was observed 5min post injection, with the concentration of arsenic 
gradually decreasing over time.  Within 24h post injection of arsenite, the arsenic content 
was largely cleared from the blood. 
 
Figure 5.1 Total arsenic concentrations (µM) in whole rabbit blood (blue), red blood cells 
(red) and plasma (green) after injection of arsenite only. Error bars indicate data ± error; 
data were collected before injection and at 5min, 20min, 40min, 1h and 2h post injection 
of arsenite, respectively. 
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5.2 Speciation of Arsenic in blood after injection of Arsenite 
Arsenic K near-edge X-ray absorption spectra of whole blood, plasma and red 
blood cells sample after injection of arsenite were collected on the HXMA beamline at 
CLS. The arsenic K-edge spectra are sensitive to the local electronic environment of the 
arsenic and oxidation states and this technique can be used to identify the chemical forms 
of arsenic present in each sample. In this study, arsenite (AsO3
3-
), arsenic triglutathione 
[As(GS)3] and a sulfur coordinated  MMA
III 
(monomethylarsonous acid) as the form of 
[CH3As(HlipS2)] where HlipS2
2-
 means the reduced lipoic acid were used as 
representative models for the potential chemical forms of arsenic (Figure 5.2). The 
spectra of whole blood collected after injection of arsenite show variability in the arsenic 
species present (Figure 5.3). Least squares fit of the As near-edge spectrum from whole 
blood 5min after injection fitted to the sum of spectra of the standard model species is 
shown in Figure 5.3. Whole blood samples from other time points were fitted using the 
same standard species; a summary of the speciation results are shown in Table 5.1. Three 
components appeared to yield the best fits to the data, As(GS)3, arsenite and 
CH3As(HlipS2).  CH3As(HlipS2)  was found to be the most abundant of all arsenic species, 
with the fraction varying from 45% to 94% of the total arsenic content in the blood.  
Comparing all samples collected between 5min to 2h post injection, the 5min time point 
had the greatest fraction of arsenite, and the lowest fraction of CH3As(HlipS2). At later 
time points, the fractions of arsenite decreased and the fractions of CH3As(HlipS2)  
increased. These results indicate that the arsenite injected into blood becomes methylated, 
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forming CH3As(HlipS2), with the formation of As(GS)3 existing as an intermediate 
during this biotransformation. The concentrations of As in whole blood samples collected 
40min post injection and later were low, resulting in less signal in the As K near-edge 
spectra. The low As concentrations in these later time points made it difficult to obtain 
accurate fractions for individual species, however, the major species being CH3As(HlipS2)  
is unmistakable. 
            
Figure 5.2 As K near-edge spectra of standard arsenic species.  
a. As(GS)3 b. CH3As(HlipS2)  c. AsO3
3-
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Figure 5.3 Least squares fit of the As K near-edge spectrum of rabbit whole blood 5min 
post injection of arsenite, fitting to the sum of spectra of standard arsenic species. 
Represented is whole blood data (dotted line), the fit to the data (solid line) and 
individual components, scaled according to their contributions to the fit: a. As(GS)3 b. 
arsenite c. CH3As(HlipS2). The residual is shown offset below. Numerical results are 
shown in Table 5.1. 
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Table 5.1 Percentage of arsenic as each arsenic species in rabbit whole blood 
samples after injection of arsenite. 
Time As(GS)3 AsO3
3-
 CH3As(HlipS2) 
5min 27(12) 28(5) 45(17) 
20min ──            11(8) 68(9) 
40min ── 10(8) 90(13) 
1hr* ── ──  92(10) 
2hr* ── ──  94(13) 
  
As K near-edge fitting results from whole blood from the rabbit injected with arsenite, 
samples represent whole blood collected 5min, 20min, 40min, 1h and 2h post injection of 
arsenite, respectively. Values derived from percentage contributions of spectra of 
standards to the best fit of the sample spectra. Figures in parenthesis show three times 
standard deviation. Tri-glutathione arsenic, arsenite, and the sulfur coordinated MMA
III 
are represented by As(GS)3, AsO3
3- 
and CH3As(HlipS2), respectively. * indicates the 
sample is dilute resulting in poor data quality precluding accurate analysis, and only the 
major component is therefore determined. 
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The As K near-edge spectra of the red blood cell fractions after injection of arsenite 
within 2h were also collected. Least squares fit of the red blood cell spectrum 5min post 
injection of arsenite was fitted to the sum of spectra of standard species (Figure 5.4). The 
remaining time points for the red blood cell fractions were fitted in the same manner; the 
results of which are shown in Table 5.2. Similar to the whole blood data, three 
components [As(GS)3, arsenite and CH3As(HlipS2)] appeared to yield the best fits, for 
the sample 5min post injection. Across all time points studied, CH3As(HlipS2) 
 
was found 
to be the most abundant of all arsenic species, with this species comprising 35% to 88% 
of the total As content in red blood cells. Arsenite was only identified 5min post injection, 
and comprised a small fraction of the total (6%).  From 5min to 20min post injection, the 
fractions of As(GS)3 decreased and finally disappeared at later time points while the 
fractions of CH3As(HlipS2) increased and became the only As species in red blood cell.  
The concentration of arsenic in red blood cells collected 40min post injection and 
later was low, resulting in lower signals in the As K near-edge spectra. Therefore, it is 
difficult to obtain accurate fractions for individual species; however, the major species of 
CH3As(HlipS2) has been detected. 
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Figure 5.4 Least squares fit of the As K near-edge spectrum of red blood cells 5min post 
injection of arsenite to the sum of spectra of standard arsenic species. Shown are the red 
blood cell data (dotted line), the fit (solid line) and the individual components, scaled 
according to their contributions to the fit: a. As(GS)3 b. arsenite c. CH3As(HlipS2). The 
residual is shown offset below. Numerical results are shown in Table 5.2.       
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Table 5.2 Percentage of arsenic as each arsenic species in rabbit red blood cells 
after injection of arsenite.    
Sample As(GS)3 AsO3
3- 
CH3As(HlipS2) 
5min 59(10) 6(4) 35(14) 
20min           34(17) ── 66(19) 
40min* ── ── 84(5) 
1hr* ── ── 86(7) 
2hr* ── ──  88(10) 
As K near-edge fitting results from red blood cells isolated from the rabbit injected with 
arsenite, samples represent red blood cells 5min, 20min, 40min, 1h and 2h post injection 
of arsenite, respectively. Values derived from percentage contributions of spectra of 
standards to the best fit of the sample spectra. Figures in parenthesis show three times 
standard deviation. Tri-glutathione arsenic, arsenite, and the sulfur coordinated MMA
III 
are represented by As(GS)3, AsO3
3- 
and CH3As(HlipS2), respectively. * indicates that 
sample is dilute resulting in poor data quality precluding accurate analysis, and only the 
major component is therefore determined. 
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The As K near-edge spectra of plasma factions after injection of arsenite within 2h 
were also collected.  Least squares fit of the plasma spectrum 5min post injection of 
arsenite was fitted to the sum of spectra of standard species. Arsenite and As(GS)3 appear 
to yield the best fit (Figure 5.5). The remaining time points for plasma fractions were 
fitted in the same manner; the results of which are shown in Table 5.3. Across all time 
points studied arsenite was found to be the most abundant of all arsenic species between 
5min and 40min post injection, with this species comprising 88% to 52% of the total As 
content in plasma. Also, more arsenite was observed in plasma fractions compared with 
whole blood or plasma at each time point.   
The concentrations of arsenic in plasma collected 1h post injection and later were 
low, resulting in lower signals in the As K near-edge spectra. Therefore, it is difficult to 
obtain accurate fractions for individual species; however, the major species of 
CH3As(HlipS2) has been detected. 
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Figure 5.5 Least squares fit of the As K near-edge spectrum of plasma 5min post 
injection of arsenite to the sum of spectra of standard arsenic species. Shown are the 
plasma data (dotted line), the fit (solid line) and the individual components, scaled 
according to their contributions to the fit: a. As(GS)3  b. arsenite. The residual is shown 
offset below. Numerical results are shown in Table 5.3. 
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Table 5.3 Percentage of arsenic as each arsenic species in plasma fractions after 
injection of arsenite.    
Sample As(GS)3  AsO3
3- 
CH3As(HlipS2) 
5min 12(5) 88(5) ── 
20min            19(18) 81(18) ── 
40min ── 52(25) 48(29) 
1hr* ── ── 55(15) 
2hr* ── ── 60(13) 
As K near-edge fitting results from plasma isolated from the rabbit injected with arsenite, 
samples represent plasma 5min, 20min, 40min, 1h and 2h post injection of arsenite, 
respectively. Values derived from percentage contributions of spectra of standards to the 
best fit of the sample spectra. Figures in parenthesis show three times standard deviation. 
Tri-glutathione arsenic, arsenite, and the sulfur coordinated MMA
III are represented by 
As(GS)3, AsO3
3- 
and CH3As(HlipS2), respectively. * indicates that sample is dilute 
resulting in poor data quality precluding accurate analysis, and only the major component 
is therefore determined. 
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5.3 Speciation of arsenc in cecotrope after injection of arsenite 
The As K near-edge spectrum of cecotrope 24h post injection of arsenite was also 
collected.  Least squares fit of the cecotrope spectrum was fitted to the sum of spectra of 
standard species (Figure 5.6). Arsenite and CH3As(HlipS2) appeared to yield the best fit 
and the results are shown in Table 5.4. CH3As(HlipS2) was found to be the most abundant 
of all arsenic species comprising 84% of total arsenic content in cecotrope. 
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Figure 5.6 Least squares fit of the As K near-edge spectrum of cecotrope 24h post 
injection of arsenite to the sum of spectra of standard arsenic species. Shown are the 
plasma data (dotted line), the fit (solid line) and the individual components, scaled 
according to their contributions to the fit: a. arsenite b. CH3As(HlipS2). The residual is 
shown offset below. Numerical results are shown in Table 5.4. 
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Table 5.4 Percentage of arsenic as each arsenic species in rabbit cecotrope sample 
after injection of arsenite.    
Sample          AsO3
3-
 CH3As(HlipS2) 
As_cecotrope     16(5)        84(6) 
As K near-edge fitting results of cecotrope from the rabbit injected with arsenite. Values 
derived from percentage contributions of spectra of standards to the best fit of the sample 
spectra. Figures in parenthesis show three times standard deviation. Tri-glutathione 
arsenic, arsenite, and the sulfur coordinated MMA
III are represented by AsO3
3- 
and 
CH3As(HlipS2),  respectively.  
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5.4 Discussion 
The above results show that after injection of arsenite into rabbit, blood arsenic 
accumulates in red blood cells as opposed to plasma. In the blood, arsenic was mostly 
bound to plasma thiols most likely being transformed to As(GS)3 within minutes of 
injection. The generally accepted pathway for biotransformation of inorganic arsenic is 
methylation (Challenger, F. 1945), and the methylation of arsenic in mammals is thought 
to take place in liver. A novel metabolic arsenic pathway, proposed by Hayakawa 
(Hayakawa et al., 2005), indicated that As(GS)3 forms as an intermediate during arsenic 
biotransformation; however, this proposal remains controversial. Our experiment results 
demonstrate that As(GS)3 is one of the main metabolites in the blood within 5-20mins 
after injection of arsenite. Within 20min post injection, the methylated species 
CH3As(HlipS2) is detected in whole blood, red blood cells and plasma fractions. This 
indicates that As(GS)3 becomes methylated forming a CH3As(HlipS2)
 
species (likely 
CH3As
III
(GS)2).  Although the detoxification pathway indicates that DMA(V) and 
MMA(V) are the end products of arsenic biotransformation, no evidence of those species 
have been detected in our experiments and longer exposures to arsenite might be needed 
to detect these. However, arsenic was rapidly eliminated and quickly became 
undetectable in our experiments. 
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Chapter 6: 
Disposition of Selenium and Arsenic after Injection of 
Selenite and Arsenite  
Two male New Zealand white rabbits (1.5-2kg) were selected for studying the fate 
of arsenic and selenium after injection of arsenite and selenite within a mammalian 
system.  Arsenite and selenite were injected to the rabbits as described in Chapter 3. The 
first rabbit was injected with prepared arsenite followed by selenite via ear vain. The 
second rabbit was injected with prepared selenite followed by arsenite. Blood and 
cecotrope samples were collected after injection at different time intervals as described in 
Chapter 3. 
6.1 Selenium and Arsenic Levels in Blood  
Arsenite and selenite were both administered to rabbits. Two different experiments 
were done – in the first which arsenite was given three minutes before selenite, and in the 
second selenite was given three minutes before arsenite. 
6.1 .1 Total Selenium and Arsenic Concentration in Blood after Injection 
of Arsenite followed by Selenite 
Total concentrations of selenium in rabbit blood after injection of arsenite and then 
followed by selenite 3min later were measured by comparing the edge jumps of the 
selenium and arsenic K near-edge spectra to those of standards of known concentrations. 
Figure 6.1 shows the total selenium concentration in whole blood (blue), red blood cell 
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(red) and plasma (green) as well as the bars indicate data±error. Errors were estimated as 
peak-peak noise amplitude using a spectroscopically unstructured region above the 
absorption edge and approximately correspond to a 99% confidence limit. While this is 
not a rigorous statistical treatment it gives a reasonable approximation of the 
uncertainties associated with concentrations estimates. There was found to be a low 
concentration of selenium present at time point 0, which is just before the injection, and 
this probably corresponds to functional selenium from that naturally present in the diet at 
a level of about 2.0 µM. Samples of whole blood, red blood cell and plasma 24h after 
injection of arsenite followed by selenite were also collected, and the selenium level was 
found to be as low as 1.7±0.4µM. The selenium levels in plasma, whole blood and red 
blood cell were all very similar, and while slightly more selenium was found in plasma, 
the difference is close to our estimated error. The highest concentration of selenium in 
blood was observed 5min post injection, with the concentration of selenium gradually 
decreasing over time.  
Figure 6.2 shows the total arsenic concentrations in whole blood (blue), red blood 
cell (red) and plasma (green) and the bars indicate data ± error. The arsenic 
concentrations in blood within 2h post injection were obtained as the same manner as 
selenium levels. From figure 6.2, there was no measureable arsenic in rabbit blood 
samples before injection. 24h post injection of arsenite followed by selenite, no 
significant amount of arsenic was detected. This indicates the arsenic content was largely 
cleared from blood 24h after injection. At each time point in Figure 6.2, more arsenic is 
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observed in red blood cell fractions compared with whole blood or plasma. The sample 
taken at 5min after injection shows the highest concentration of arsenic in blood, and 
thereafter the concentrations of arsenic gradually decrease, until 24hr after injection, the 
arsenic content has been largely cleared from the blood.  
Figures 6.1 and 6.2 indicate that at each time point post injection, blood selenium 
levels are much higher than arsenic levels. The likely reason for this is that arsenite is 
cleared from blood rapidly and upon selenite injection 3min later; most arsenic has 
already been removed from blood. Secondly, our experimental results indicate that 
arsenite has a higher elimination rate than selenium. 
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Figure 6.1 Total selenium concentrations (µM) in whole blood (blue), red blood cell (red) and 
plasma (green) collected from the rabbit after injection of arsenite followed by selenite, bars 
indicate data ± error, data were collected before injection, and at 5min, 20min, 40min, 1hr and 
2hr post injection of arsenite followed by selenite, respectively. 
        
Figure 6.2 Total arsenic concentrations (µM) in whole blood (blue), red blood cell (red) and 
plasma (green) collected from the rabbit after injection of arsenite followed by selenite, bars 
indicate data ± error, data were collected before injection, and at 5min, 20min, 40min, 1hr and 
2hr after injection of arsenite followed by selenite, respectively. 
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6.1.2 Total Selenium and Arsenic Concentration in Blood after Injection 
of Selenite followed by Arsenite 
Total concentrations of selenium in rabbit blood after injection of selenite and 3min 
later followed by arsenite were measured by comparing the edge jump of either selenium 
or arsenic K near-edge spectra to standards of known concentrations. Figure 6.3 shows 
the total selenium concentration and Figure 6.4 shows the total arsenic concentration in 
whole blood (blue), red blood cell (red), plasma (green) and the bars indicate data±error. 
Both selenium and arsenic concentrations are measured in the same manner. Before 
injection, a level of 2.2 µM of selenium was detected. No observable levels of arsenic 
were present in blood before injection. The highest concentrations of both selenium and 
arsenic in blood were observed 5min post injection, with the concentration of both 
gradually decreasing over time. Within 24h post injection, the selenium content reached a 
level of 1.2±0.5 µM while the arsenic content was largely cleared from the blood. The 
selenium levels in plasma, whole blood and red blood cell were all very similar, and 
while there may be slightly more selenium in plasma (Figure 6.3), this difference is close 
to our estimated error. At each time point in Figure 6.4, more arsenic was observed in red 
blood cell fractions compared with whole blood or plasma.  
From Figure 6.3 and 6.4, the selenium levels were consistently higher than the 
arsenic levels at all time points. This indicates that irrespective of whether arsenite is 
injected before or after selenite, arsenic has a higher elimination rate and it can be 
removed from blood faster than selenium.  
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Figure 6.3 Total selenium concentrations (µM) in whole blood (blue), red blood cell (red) and 
plasma (green) collected from the rabbit after injection of selenite followed by arsenite, bars 
indicate data± error, data were collected before injection and at 5min, 20min, 40min, 1hr and 2hr 
after injection of selenite followed by  arsenite, respectively. 
        
Figure 6.4 Total arsenic concentrations (µM) in whole blood (blue), red blood cell (red) and 
plasma (green) collected from the rabbit after injection of selenite followed by arsenite, bars 
indicate data± error, data were collected before injection, and at 5min, 20min, 40min, 1hr and 2hr 
after injection of selenite followed by arsenite, respectively. 
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6.2 Speciation of Arsenic and Selenium after Injection of Selenite and 
Arsenite  
Both arsenic and selenium K near-edge spectra of whole blood, red blood cells and 
plasma samples after injection of arsenite and selenite were collected. The arsenic or 
selenium K-edge spectra are sensitive to the local electronic environment of the arsenic 
or selenium and their oxidation states, and this technique can be used to identify the 
chemical forms of arsenic and selenium present in each sample. In this study, Figure 6.5 
shows representative models for the potential chemical forms of arsenic and Figure 6.6 
shows the potential selenium models. Other arsenic or selenium species were also 
considered as potential models but the analysis shows insignificant fractions in all blood 
samples.  
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Figure 6.5 As K near-edge spectra of standard arsenic species.  
a. As(GS)3 (arsenic triglutathione) 
b. (CH3)3As=O (trimethylarsine oxide) 
c. [(GS)2AsSe]
-
 ( seleno-bis(S-glutathionyl) arsinium ion) 
d. CH3As(HlipS2)  (a sulfur coordinated  MMA
III
) 
e. AsO3
3-
 (arsenite) 
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Figure 6.6 Selenium K near-edge spectra of standard selenium species.  
a. SeO3
2-
(selenite) 
b. α-Se (elemental selenium)  
c. [(GS)2AsSe]
-
 ( seleno-bis(S-glutathionyl) arsinium ion) 
d. HSe
-
 (selenide) 
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6.2.1 Speciation of Arsenic and Selenium after Injection of Arsenite 
followed by Selenite 
Both arsenic and selenium K near edge spectra were collected after injection of 
arsenite followed by selenite. Least squares fittings of the As and Se near-edge spectrum 
from red blood cell 5min post injection to the sum of spectra of the standard model 
species are shown in Figures 6.7 & 6.8. Whole blood, red blood cell and plasma samples 
from other time points were fitted using the same standard species; the summaries of the 
speciation results are shown in Tables 6.1 & 6.2. 
These results indicate that the arsenite and selenite injected into blood forms 
[(GS)2AsSe]‾, and some arsenic becomes methylated, forming species similar to 
CH3As(HlipS2) and MMA
V
. In red blood cells (Figure 6.1), [(GS)2AsSe]‾ was found to 
be the most abundant arsenic species, with the fraction varying from 99% to 43%.  
[(GS)2AsSe]‾ was the only arsenic species detected at 40min post injection of arsenite 
followed by selenite. At later time points in red blood cell, CH3As(HlipS2) was also 
found, and the fractions of CH3As(HlipS2) increased while the fractions of [(GS)2AsSe]‾  
decreased. This suggests that [(GS)2AsSe]‾ was formed in red blood cell in agreement 
with earlier work (Gailer et al., 2000). Plasma samples were fitted in the same manner 
and two components appear to yield the best fits to the data; CH3As(HlipS2) and MMA
V
. 
The concentrations of arsenic in plasma collected 5min post injection and later were low, 
resulting in small signals for the As K near-edge spectra with correspondingly poor signal 
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to noise. Because of this it is difficult to obtain accurate fractions for individual species; 
however, the data suggest that both CH3As(HlipS2) and MMA
V
 are present.   
A summary of selenium speciation results of whole blood, red blood cell and 
plasma samples after injection of arsenite followed by selenite is shown in Table 6.2. In 
whole blood and red blood cell samples, four components yield the best fits to the data; 
[(GS)2AsSe]‾, HSe
-
, α-Se and SeO3
2- 
. HSe
-
 and α-Se were found to be the most abundant 
of all selenium species in whole blood and red blood cell samples within 2h post injection. 
Comparing all samples collected between 5min to 2h post injection, the 20min time point 
had the greatest fraction of [(GS)2AsSe]‾ in whole blood and red blood cells. At later 
time points, the fractions of [(GS)2AsSe]‾ decreased in whole blood and red blood cells. 
Also, more [(GS)2AsSe]‾ was observed in red blood cell fractions compared with whole 
blood or plasma at each time point. No [(GS)2AsSe]‾ species was detected in plasma 
samples with 2h post injection. Two components appeared to yield the best fits to the 
plasma data, α-Se and SeO3
2- 
.  
Figure 6.9 shows the kinetics of [(GS)2AsSe]‾ in red blood cells 2h post injection of 
arsenite and then followed by selenite. The concentrations of [(GS)2AsSe]‾  are derived 
from  total Se/As concentration and Se/As speciation results. From figure 6.9, we can 
demonstrate that the kinetics of [(GS)2AsSe]‾ in red blood cell after injection of arsenite 
and then followed by selenite is approximately first order.  From figure 6.9, the half-life 
of [(GS)2AsSe]‾ can be calculated as t1/2=27.4min derived from selenium concentration 
(upper figure) and t1/2=25.6min derived from arsenic concentration(lower figure). Given 
the various errors implicit in obtaining these values, they are in remarkable agreement.  
75 
 
          
Figure 6.7 Least squares fit of the As K near-edge spectrum of red blood cell 5min post 
injection of arsenite followed by selenite to the sum of spectra of standard arsenic species. 
Shown are the red blood cell data (dotted line), the fit (solid line) and the individual 
component, scaled according to its contribution to the fit: [(GS)2AsSe]
-
. The residual is 
shown offset below. Numerical results are shown in Table 6.1. 
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Figure 6.8 Least squares fit of the spectrum of rabbit red blood cell 5min after injection 
of arsenite followed by selenite to the sum of spectra of standard selenium species. 
Shown are the red blood cell data (dotted line), the fit (solid line) and the individual 
components, scaled according to their contributions to the fit: a. HSe
-
 b. SeO3
2- 
c. α-Se  
d. [(GS)2AsSe]
-
 The residual is shown offset below. Numerical results are shown in Table 
6.2. 
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Table 6.1 Percentage of arsenic as each arsenic species in rabbit blood samples 
after injection of arsenite followed by selenite.    
Sample [(GS)2AsSe]‾ CH3As(HlipS2) MMA
V
 
AsSe_w1_5min 86(12) 8(4) 6(3) 
AsSe_w2_20min 73(8) 13(7) 14(6)  
AsSe_w3_40min 48(9) 34(3) 18(5) 
AsSe_w4_1hr 27(3) 54(8) 19(6) 
AsSe_w5_2hr 22(3) 58(4) 20(3) 
AsSe_R1_5min 100(1) ── ── 
AsSe_R2_20min 100(3) ── ── 
AsSe_R3_40min 100(3) ── ── 
AsSe_R4_1hr            55(6) 45(9) ── 
AsSe_R5_2hr 45(3) 55(4) ── 
AsSe_PL1_5min* ── 78(13)  22(10) 
AsSe_PL2_20min* ── 51(10) 49(8) 
As K near-edge fitting results from whole blood (W), red blood cells (R) and plasma (PL) 
samples from the rabbit injected with arsenite followed by selenite, within 2h post 
injection. Values derived from percentage contributions of spectra of standards to the best 
fit of the sample spectra. Figures in parenthesis show three times standard deviation. 
Seleno-bis(S-glutathionyl) arsinium ion, (2-methyl-1,3,2-dithiarsinan-4-yl) pentanoic 
acid and dimethlyarsinic acid are represented by [(GS)2AsSe]
-
, CH3As(HlipS2) and 
MMA
V
, respectively. * indicates that sample is dilute resulting in poor data quality 
precluding accurate analysis, and only the major component is therefore determined. 
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Table 6.2 Percentage of selenium as each selenium species in rabbit blood samples 
after injection of arsenite followed by selenite.    
Sample [(GS)2AsSe]‾ HSe
-
 α-Se  SeO3
2-
 
AsSe_w1_5min 8(1) 23(6) 54(3) 13(3) 
AsSe_w2_20min 17(1) 14(5) 57(2) 12(2) 
AsSe_w3_40min 9(1) 28(7) 52(3) 10(3) 
AsSe_w4_1hr 5(1) 34(5) 51(2) 8(2) 
AsSe_w5_2hr 4(1) 35(5) 50(3) 11(3) 
AsSe_R1_5min 18(1) 40(5) 34(3) 8(2) 
AsSe_R2_20min 41(1) 27(1) 26(2) 6(2) 
AsSe_R3_40min 23(1) 37(2) 36(2) 3(1) 
AsSe_R4_1hr 13(2) 40(7) 44(3) 6(3) 
AsSe_R5_2hr 9(2) 34(5) 50(3) 6(2) 
AsSe_PL1_5min ── ── 78(3) 20(3) 
AsSe_PL2_20min ── ── 76(1) 24(1) 
AsSe_PL3_40min           ── ── 75(3) 27(3) 
AsSe_PL4_1hr            ── ── 74(2) 26(2) 
AsSe_PL5_2hr ── ── 73(2) 26(2) 
Edge fitting results of whole blood (W), red blood cells (R) and plasma (PL) samples 
from rabbit treated by arsenite followed by selenite, from 5mins after injection to 2hr 
after injection, respectively. Values derived from percentage contributions of spectra of 
standards to the best fit of the sample spectra. Figures in parenthesis show three times 
standard deviation. Seleno-bis (S-glutathionyl) arsinium ion, selenide, elemental 
selenium, selenite are represented by [(GS)2AsSe]‾, HSe
-
, α-Se and SeO3
2- 
,
 
respectively. 
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Figure 6.9 The concentrations of [AsSe(GS)2]
-
 in red blood cell samples vs. time within 
2h post injection of arsenite followed by selenite derived from Se (upper) and As (lower) 
speciation results; inside figures show the semilog plots.  
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6.2.2 Speciation of Arsenic and Selenium after Injection of Selenite 
followed by   Arsenite  
Both arsenic and selenium K near-edge spectra of whole blood, red blood cells and 
plasma samples after injection of selenite followed by arsenite were collected. Figure 
6.10 and Figure 6.11 show the variation of selenium and arsenic K near-edge spectra in 
whole blood, red blood cell and plasma spectra 5min post injection. The dotted vertical 
line helps emphasize the energy variation in the near edge spectra. Arsenic and Selenium 
near-edge spectra were fitted to the sum of spectra of the standard model species in 
Figure 6.5 and Figure 6.6.  
.  
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Figure 6.10 Arsenic K near-edge spectra of whole blood, red blood cell and plasma from 
the rabbit 5min after injection of selenite followed by arsenite. Dotted vertical line helps 
to emphasize the energy variation in the near edge. 
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Figure 6.11 Selenium K near-edge spectra of whole blood, red blood cell and plasma 
from the rabbit 5min after injection of selenite followed by arsenite. The dotted vertical 
line helps to emphasize the energy variation in the near edge. 
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A summary of the arsenic speciation results after injection of selenite followed by 
arsenite is shown in Table 6.3. [(GS)2AsSe]‾ was detected at 5min and 20min post 
injection in whole blood and red blood cell. At 5min time point, [(GS)2AsSe]‾ had the 
highest fraction of 61% of total arsenic in whole blood and a fraction 72% in red blood 
cell. At 20min time point, [(GS)2AsSe]‾ decreased to 7% of total arsenic in whole blood 
and 14% in red blood cell. At later time points, no significant amount of [(GS)2AsSe]‾  
was found in whole blood and red blood cell samples. No evidence of [(GS)2AsSe]‾ was 
detected in plasma samples either. CH3As(HlipS2)  was found to be the most abundant of 
all arsenic species in whole blood within 2h post injection. As(GS)3 was found in whole 
blood from 5min to 20min post injection, while it was present in red blood cell from 
5min to 1h post injection. 20min after injection, As(GS)3 was methylated to MMA
V
 and 
was largely cleared from whole blood. In red blood cell samples, CH3As(HlipS2)  and 
As(GS)3 were the most abundant arsenic species 20min post injection. In plasma samples, 
arenite was found to be the most abundant of all arsenic species between 5min and 1h 
post injection, with this species comprising 91% to 26% of the total As content. 
CH3As(HlipS2)  and MMA
V
 were detected in plasma samples and the fraction of these 
arsenic species increased between 40min and 2h post injection. 
A summary of the selenium speciation results after injection of selenite followed by 
arsenite is shown in Table 6.4. [(GS)2AsSe]‾ was found 5min and 20min post injection in 
whole blood and red blood cell. At 5min time point, [(GS)2AsSe]‾ had the highest 
fraction of 20% of total selenium in whole blood and a fraction 35% in red blood cell. At 
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20min time point, [(GS)2AsSe]‾ decreased to 5% of total selenium in whole blood and 
8% in red blood cell. At later time points, no significant amount of [(GS)2AsSe]‾  was 
found in whole blood and red blood cell samples. No evidence of [(GS)2AsSe]‾ was 
detected in plasma samples either. Across all time points studied, HSe
-
 and α-Se were 
found to be the most abundant of all selenium species, with HSe
-
 comprising 35% to 66% 
of the total selenium content; while the fraction of α-Se varying from 29% to 65% of the 
total selenium content in whole blood, red blood cell and plasma. From 5min to 20min 
post injection, the fraction of 3% to 4% of selenite was also been detected in whole blood 
and red blood cell.  
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Table 6.3 Percentage of arsenic as each arsenic species in rabbit blood samples 
after injection of selenite followed by arsenite.    
Sample [(GS)2AsSe]‾ AsO3
3-
 CH3As(HlipS2) As(GS)3 MMA
V
 
SeAs_w1_5min 61(6) ── 4(2) 37(6) ── 
SeAs_w2_20min 7(3) ── 81(5) 11(2) ── 
SeAs_w3_40min ── ── 95(3) ── 5(2) 
SeAs_w4_1hr ── ── 86(5) ── 15(3) 
SeAs_w5_2hr ── ── 75(7) ── 25(4) 
SeAs_R1_5min 72 (6) ── ── 27(6) ── 
SeAs_R2_20min 14(8) ── 24(5) 62(7) ── 
SeAs_R3_40min ── ── 46(8) 53(5) ── 
SeAs_R4_1hr ── ── 55(6) 45(4) ── 
SeAs_R5_2hr ── ── 85(6) ── 15(5) 
SeAs_PL1_5min ── 91(4) 7(2) ── ── 
SeAs_PL2_20min ── 88(7) 12(8) ── ── 
SeAs_PL3_40min ── 63(8) ── 13(7) 23(4) 
SeAs_PL4_1hr ── 26(6) ── 27(7) 47(5) 
SeAs_PL5_2hr ── ── ── 38(9) 62(9) 
As K near-edge fitting results from whole blood (W), red blood cells (R) and plasma (PL) 
samples from the rabbit injected with selenite followed by arsenite, within 2h post 
injection. Values derived from percentage contributions of spectra of standards to the best 
fit of the sample spectra. Figures in parenthesis show three times standard deviation. 
Seleno-bis(S-glutathionyl) arsinium ion, arsenite, tri-glutathione arsenic, (2-methyl-1,3,2-
dithiarsinan-4-yl) pentanoic acid and monomethylarsonic acid are represented by 
[(GS)2AsSe]
-
,  AsO3
3-
, As(GS)3, CH3As(HlipS2) and MMA
V
, respectively.  
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Table 6.4 Percentage of selenium as each selenium species in rabbit blood samples 
after injection of selenite followed by arsenite.    
Sample [(GS)2AsSe]‾ HSe
-
 α-Se  SeO3
2-
 
SeAs_w1_5min 20(2) 31(3) 45(2) 4(2) 
SeAs_w2_20min 5(1) 36(4) 55(2) 3(1) 
SeAs_w3_40min ── 55(5) 45(5) ── 
SeAs_w4_1hr ── 55(5) 45(5) ── 
SeAs_w5_2hr ── 60(6) 40(5) ── 
SeAs_R1_5min 35(2) 32(4) 29(3) 4(2) 
SeAs_R2_20min 8(2) 48(3) 40(3) 3(2) 
SeAs_R3_40min ── 67(4) 33(3) ── 
SeAs_R4_1hr ── 66(4) 34(3) ── 
SeAs_R5_2hr ── 66(4) 34(6) ── 
SeAs_PL1_5min ── 35(6) 65(3) ── 
SeAs_PL2_20min ── 42(3) 58(3) ── 
SeAs_PL3_40min ── 42(10) 58(5) ── 
SeAs_PL4_1hr ──     55(5) 45(5) ── 
SeAs_PL5_2hr ── 49(5) 51(5) ── 
Edge fitting results of whole blood (W), red blood cells (R) and plasma (PL) samples 
from rabbit treated by selenite followed by arsenite, from 5mins after injection to 2hr 
after injection, respectively. Values derived from percentage contributions of spectra of 
standards to the best fit of the sample spectra. Figures in parenthesis show three times 
standard deviation. Seleno-bis (S-glutathionyl) arsinium ion, selenide, elemental 
selenium and selenite are represented by [(GS)2AsSe]‾, HSe
-
, α-Se  and SeO3
2-
,
 
 
respectively. 
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6.3 Speciation of Arsenic in Cecotrope after Injection of Arsenite and 
Selenite 
The spectra of cecotrope samples 24h post injection of both arsenite and selenite 
were also collected. Least squares fits of spectra of cecotrope sample after injection of 
selenite followed by arsenite to the sum of spectra of standard species are shown in 
Figure 6.12 & 6.13. Cecotrope sample after injection of arsenite followed by selenite was 
fitted to the standard selenium and arsenic species of in the same manner; the results of 
which are shown in Tables 6.5 & 6.6.  
The samples were random picked up from a pool of cecotrope samples the rabbit 
produced over night, and the experimental results were primary since it is hard to detect 
when exactly the cecotrope samples were produced post injection. From Table 6.5, 
[(GS)2AsSe]
-
 was detected in both ceocotrope samples regardless of the order of the 
injection of arsenite and selenite. Cecotrope sample collected from the rabbit which was 
injected arsenite first, had a fraction of 78% of [(GS)2AsSe]
- 
 and the other arsenic 
species found was arsenite. A fraction of 45% of (CH3)3As=O was found in the cecotrope 
sample from the rabbit which was injected by selenite first. It is still unclear why 
(CH3)3As=O is formed but one possible guess is (CH3)3As=O is the metabolite of some 
bacteria from the gut of the rabbit. 
Table 6.6 shows the least square fitting results of selenium spectra of cecotrope 
samples. There were four components in selenium speciation of both cecotrope samples, 
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[(GS)2AsSe]
-
, SeO3
2-,GS-Se-GS and R-Se-R. Among of the four components, GS-Se-
GS had the greatest fraction at around 50% of the total selenium content, and 
[(GS)2AsSe]
-
 had the second greatest fraction as well as selenite had the smallest fraction. 
                     
Figure 6.12 Least squares fit of the As K-edge spectrum of cecotrope from a rabbit 24 
hours after injection by selenite followed by arsenite. The spectrum was fitted to the sum 
of spectra of model species. Figure shows the cecotrope data (dotted line), the fit (black 
line) and the individual components, scaled according to their contributions to the fit.   
a. (CH3)3As=O b. [(GS)2AsSe]
- 
c. As(GS)3  d. arsenite 
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Figure 6.13 Least squares fit of the Se K-edge spectrum of cecotrope from a rabbit 24 
hours after injection by selenite followed by arsenite. The spectrum was fitted to the sum 
of spectra of model species. Figure shows the cecotrope data (dotted line), the fit (black 
line) and the individual components, scaled according to their contributions to the fit.  
a. GS-Se-GS b. R-Se-R c. [(GS)2AsSe]
-
 d. SeO3
2-
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Table 6.5 Percentage of arsenic as each arsenic species in rabbit cecotrope samples 
after injection of arsenite and selenite, either in this order (SeAs) or reversed (AsSe).  
Sample [(GS)2AsSe]
-
 CH3As(HlipS2) AsO3
3- 
As(GS)3 (CH3)3As=O 
SeAs 24(9) ── 8(3) 23(9) 45(3) 
AsSe 71(2) 29(3) ── ── ── 
Edge fitting results of cecotrope sample from rabbit injected by selenite followed by 
arsenite (SeAs) and cecotrope sample from rabbit injected arsenite followed by selenite 
(AsSe). Values derived from percentage contributions of spectra of standards to the best 
fit of the sample spectra. Figures in parenthesis show three times standard deviation. 
Seleno-bis(S-glutathionyl) arsinium ion, sulfur coordinated MMA
III
, arsenite, arsenic tri-
glutathione and trimethylarsine oxide are represented by [(GS)2AsSe]
-
, CH3As(HlipS2), 
AsO3
3- 
, As(GS)3and (CH3)3As=O, respectively. 
 
Table 6.6 Percentage of selenium as each selenium species in rabbit cecotrope 
samples after injection of arsenite and selenite, either in this order (SeAs) or reversed 
(AsSe).    
Sample [(GS)2AsSe]
-
 SeO3
2- 
GS-Se-GS R-Se-R 
SeAs 22(6) 3(2) 53(6) 23(5) 
AsSe 37(7) 8(3) 47(7) 13(5) 
Edge fitting results of cecotrope sample from rabbit injected by selenite followed by 
arsenite (SeAs) and cecotrope sample from rabbit injected arsenite followed by selenite 
(AsSe). Values derived from percentage contributions of spectra of standards to the best 
fit of the sample spectra. Figures in parenthesis show three times standard deviation. 
Seleno-bis(S-glutathionyl) arsinium ion, selenite, selenodiglutathione and 
selenomethionineare represented by [(GS)2AsSe]
-
, SeO3
2-,GS-Se-GS and R-Se-R, 
respectively. 
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6.4 Discussion 
The results above show that after injection of both selenite and arsenite into rabbit, 
regardless of the order of injection, blood arsenic accumulates in red blood cells as 
opposed to plasma; [(GS)2AsSe]
-
 was found in red blood cell 5min post injection but not 
in plasma. This indicates that [(GS)2AsSe]
-
 is assembled in red blood cell and is formed 
in blood very rapidly. Earlier studies have also shown similar results (Gailer et al., 2000) 
When arsenite was injected into rabbit before selenite, [(GS)2AsSe]
-
 was detected 
in red blood cell at 100% of total arsenic in blood between 5min and 40min post injection. 
[(GS)2AsSe]
-
 started to eliminate from blood 1h post injection, and CH3As(HlipS2) was 
the main metabolite in red blood cell within 2hrs after injection. The arsenic in plasma 
fractions presented as the methylated species similar to CH3As(HlipS2) and MMA
V
.  Our 
experimental results demonstrate that 71% of total arsenic in the form of [(GS)2AsSe]
-
 is 
one of the end products of arsenic in cecotrope sample after injection.  
When arsenite was injected into rabbit after selenite, [(GS)2AsSe]
-
 was found in red 
blood cell 5min and 20min post injection at a fraction of 72% and 14%, respectively. At 
40min post injection, [(GS)2AsSe]
-
 was not detected in blood which indicates 
[(GS)2AsSe]
-
 had been largely removed from blood stream. Although [(GS)2AsSe]
- 
was 
first found at 5min time point, it is very likely that [(GS)2AsSe]
- 
would be detected in red 
blood cell before 5min at a fraction higher than 72% of total arsenic. Based on our 
experiment results, one possible guess is that [(GS)2AsSe]
-
 is formed in red blood cell as 
the moment arsenic and selenium meet in blood and then start to be removed from blood 
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within 40min. 40min post injection, [(GS)2AsSe]
-  
had been removed from blood and thus 
CH3As(HlipS2) and MMA
V
 were found to be the main metabolites of arsenic in blood. 
24hr after injection, [(GS)2AsSe]
-  
had also been detected in cecotrope sample.  
In conclusion, when administration arsenite and selenite into rabbit, the nontoxic 
species of [(GS)2AsSe]
-  
will be formed in red blood cell very rapidly and then start to be 
removed from blood system within 40min post injection.  
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Chapter 7: General Discussion and Future Work 
7.1 The Behaviour of Arsenic in the Absence and Presence of 
Selenium 
In this study, X-ray absorption spectroscopy was used to investigate the molecular-
level disposition of arsenic and selenium in rabbit upon the treatment of selenite, arsenite 
or both. Whole blood, red blood cell, plasma and cecotrope samples were examined in 
this study. In the absence and presence of selenium, arsenic behaves very differently. In 
the absence of selenium, arsenic rapidly accumulates in red blood cells as opposed to 
plasma. In our experiments, the end product of arsenic in blood was found to be related to 
the mono-methylated model CH3As(HlipS2) which contains arsenic coordinated by two 
thiolates and a single methyl group 2h post injection of arsenite to the rabbit. In addition, 
species resembling CH3As(HlipS2) were also detected in cecotrope samples at a fraction 
of 84% of total arsenic content 24h post injection.  The finding of As(GS)3 species in 
blood after injection of arsenite supports the hypothesis that As(GS)3 is an intermediate 
during arsenic biotransformation in the metabolic pathway for inorganic arsenic 
(Hayakawa et al., 2005). Hayakawa also suggested that the end products of arsenic 
metabolism are MMA(III) and DMA(III). However, in our experiments, no evidence of 
those methylated species was found, although it is possible that they might be found in 
urine. 
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In the presence of selenium, when rabbit was injected with selenite followed by 
arsenite, As(GS)3 and CH3As(HlipS2) were detected in red blood cells and plasma 
samples within 2hr post injection, which also suggesting that the transformation from 
As(GS)3 to CH3As(HlipS2) was in process during arsenic metabolism. However, when 
rabbit was injected with arsenite followed by selenite, As(GS)3 cannot be detected in 
blood samples but CH3As(HlipS2) was still found. It is possible that the transformation 
from As(GS)3 to CH3As(HlipS2) was too fast to detect. Regardless of the order of 
injection, MMA
V
 was found to be the end product after injection of arenite and selenite.  
When selenite and arsenite were given together into the rabbit, regardless of the 
order of the injections, the complex -- [(GS)2AsSe]
-
 was formed in red blood cell very 
rapidly (within 5mins post injection). Our experimental results demonstrated that 
99%±1% of total arsenic detected in blood appears in the form of [(GS)2AsSe]
-
 at the 
shortest time measured. 40min after injection, [(GS)2AsSe]
- 
had largely been eliminated 
from blood. This shows that [(GS)2AsSe]
-
 was removed from red blood cells. 
Researchers in Alberta reported that in vitro red blood cells don’t transport [(GS)2AsSe]
- 
but did not use plasma (Carew and Leslie, 2010). However, our experimental results 
indicate that in vivo, red blood cells probably do transport [(GS)2AsSe]
-
.  Although it is 
uncertain how [(GS)2AsSe]
-
 gets out from red blood cells, it is likely that some sort of 
ATP-driven transportation is involved. Also, compared to selenium, the elimination rate 
of arsenic in blood was higher. When arsenite was injected into rabbit after selenite, 
[(GS)2AsSe]
-
 could not be detected in blood 40min post injection, but it was found in the 
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blood system 2hr post injection when the dose was given in reverse. This indicated that 
[(GS)2AsSe]
- 
 was eliminated from the blood faster when selenite was injected to the 
rabbit prior to arsenite. These findings suggested that the presence of selenite present in 
the system speeds up the removal of arsenic from the blood. Our experimental results 
also indicate that in rabbit injected selenium would deplete the body load of arsenic and 
toxic inorganic arsenic can be converted into the excretale species of [(GS)2AsSe]
-
.  
It is very important to understand the metabolism of [(GS)2AsSe]
-
 and its excretion 
pathways. In addition to examine the cecotrope samples collected after injection of both 
arsenite and selenite, feces samples were collected and examined on the beamline. No 
significant amount of arsenic was detected. Due to the limitation of beamtime availability 
and the experimental loads, only blood and cecotrope samples were examined in this 
thesis. However, urine and bile samples are strongly suggested to be tested in the future 
work.  
Eextrapolating from our rabbit results, the formation of [(GS)2AsSe]
-
 in blood 
should also consume the body load of arsenic in humans. Therefore, administering 
selenium supplements might provide a simple but highly effective treatment of 
Bangladeshi people who are suffering from long-term chronic low-level arsenic 
poisoning. 
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7.2 Future Work 
The studies described in this thesis provide important information on the 
biochemistry of arsenic and selenium. In future work, the fate of arsenite and selenite 
following oral administration could be studied. Blood and cecotrope samples should be 
collected at different time intervals.  Due to individual and bioavailability differences in 
different rabbits, various doses of arsenite and selenite should be tested to the rabbits. 
Both arsenic and selenium K near-edge spectra need to be recorded and analyzed for 
quantities and speciation studies. These results will give us a better idea of how fast 
[(GS)2AsSe]
-
 is formed in blood sample when arsenite and selenite is taken orally and 
how fast it is removed from blood. Urine and bile samples at different time intervals after 
injection should also be collected. Examination of urine and bile samples will indicate 
how [(GS)2AsSe]
-
 would be cleared from the body other than excreted in cecotropes. 
 
 
 
97 
 
References 
Antman, K. H. (2001) ―The History of Arsenic Trioxide in Cancer Therapy‖. The 
oncologist, 6: 1–2. 
Aposhian, H. V., and Aposhian, M. M. (2006) ―Arsenic toxicology: five questions‖. 
Chemical Research in Toxicology, 19: 1-15.  
Aposhian, H. V., Zheng, B., Aposhian, M. M., Le, X. C., Cebrian, M. E., Cullen, W., 
Zakharyan, R. A., Ma, M., Dart, R. C., Cheng, Z., et al. (2000) ―DMPS-arsenic challenge 
test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA
III
), 
excreted in human urine‖. Toxicology and Applied Pharmacology, 165: 74–83. 
Baum, M.K., Shor-Posner, G., Lai, S., Zhang, G., Lai, H., Fletcher, L.A., Sauberlich, H., 
Page, J.B. (1997) ―High risk of HIV-related mortality is associated with selenium 
deficiency‖. Journal of Acquired Immune Deficiency Syndromes and Human 
Retrovirology, 15: 370–4. 
Berzelius, J. J. (1818) ―Lettre de M. Berzelius à M. Berthollet sur deux métaux 
nouveaux‖ (Letter from Mr. Berzelius to Mr. Berthollet on two new metals), Annales de 
chimie et de physique, 2: 199-206. 
Bleys, J., Navas-Acien, A., and Guallar, E.  (2007) ―Serum selenium and diabetes in U.S. 
adults‖. Diabetes Care, 30: 829–34. 
Breslow, E.L., and Cengage, G. (2002) ―Arsenic‖. Encyclopedia of Public Health. 
<http://www.enotes.com/public-health-encyclopedia/arsenic> 
Burk, R. F., Hill, K. E.  (2009) ―Selenoprotein P-Expression, functions, and roles in 
mammals‖. Biochimica et Biophysica Acta, General Subjects, 1790: 1441-1447. 
98 
 
Caravati, E.M. (2004) ―Arsenic and arsenic gas‖. In Dart, R.C. and Carabati, E.M.(eds) 
Medical toxicology,1393–1401, Philadelphia, Lippincott Williams & Wilkins.  
Carew, M. W., and Leslie, E. M. (2010) ―Selenium-dependent and -independent transport 
of arsenic by the human multidrug resistance protein 2 (MRP2/ABCC2): implications for 
the mutual detoxification of arsenic and selenium‖.  Carcinogenesis, 31: 1450-1455.  
Carter, D. E., Aposhian, H. V., and Gandolfi, A. J. (2003) ―The metabolism of inorganic 
arsenic oxides, gallium arsenide, and arsine: A toxicochemical review‖. Toxicology and 
Applied Pharmacology, 193: 309-334. 
Chaudhuri, A.  (2004) ―Dealing with arsenic contamination in Bangladesh‖. MIT 
Undergrad Research Journal, 11: 25–30. 
Chen, X., Y, G., Chen, J., Chen, X., Wen, X., and Ge, K. (1980) ―Studies on the relations 
of selenium and Keshan disease‖.  Biological Trace Element Research, 2:91-107. 
CLS (Canadian Light Source Inc) (2010) ―Canadian Light Source Virtual Tour‖. 
<http://www.lightsource.ca/education/vr.php> 
Cuvin-Aralar, M.L., and Furness, R.W. (1991) Mercury and selenium interaction: a 
review. Ecotoxicology and Environmental Safety, 21:348-64. 
Du Bois, K.P., Moxon, A. L., and Olson, O.E. (1940) ―Further studies on the 
effectiveness of arsenic in preventing selenium poisoning‖. Journal of Nutrition, 19:477.  
Elder, F. R., Gurewitsch, A. M., Langmuir, R. V., and Pollock, H. C. (1947) ―Radiation 
from Electrons in a Synchrotron‖.  Physical Review, 71:829-830. 
99 
 
Emsley, John. (2001) ―Nature's Building Blocks: An A-Z Guide to the Elements‖. 40-45, 
Oxford, New York, Oxford University Press. 
Gailer, J., George, G. N., Pickering, I.J., Prince, R. C., Ringwald, S. C., Pemberton, J. E., 
Glass, R. S., Younis, H. S., Deyoung, D. W., and Aposhian, H. V. (2000) ―A metabolic 
link between arsenite and selenite: The Seleno-bis(S-glutathionyl) Arsinium Ion‖. 
Journal of the American Chemical Society, 122: 4637-4639 
Gailer, J., George, G.N., Pickering, I.J., Madden, S, Prince, R.C., Yu, E.Y., Denton, M.B., 
Younis H.S., and Aposhian, H.V. (2000) ―The Structural Basis of the Antagonism 
between Inorganic Mercury and Selenium in Mammals‖.  Chemical Research in 
Toxicology, 13: 1135-1142. 
Gailer, J., Madden, S., Burke, M. F., Denton, M. B., and Aposhian, H. V. (2000) 
―Simultaneous multielement-specific detection of a novel glutathione-arsenic-selenium 
ion [(GS)2AsSe]
-
 by ICP-AES after micellar size-exclusion chromatography‖. Applied 
Organometallic Chemistry, 14: 355-363. 
Gailer, J., Ruprecht, L., Reitmeir, P., Benker, B., and Schramel, P. (2004) ―Mobilization 
of exogenous and endogenous selenium to bile after the intravenous administration of 
environmentally relevant doses of arsenite to rabbits‖. Applied Organometallic Chemistry, 
18 : 670-675. 
George, G.N. (2010) ―Speciation of Mixtures‖. <http://www-
conf.slac.stanford.edu/smbxas-ss/2010/talks/George_06.pdf> 
George, G.N. and Pickering, I.J. (2007) ―X-ray Absorption Spectroscopy in Biology and 
Chemistry‖.  In Vasili Tsakanov and Helmut Wiedemann (eds), Brilliant Light in Life 
and Material Sciences, 97-119, New York, Springer. 
100 
 
George, G.N., and Pickering, I.J. (2000) EXAFSPAK. <http://www-
ssrl.slac.stanford.edu/~george/exafspak/manual.pdf> 
 
Gomez-Caminero, A., Howe, P., Hughes, M., Kenyon, E., Lewis, D.R., Moore, M., Ng, 
J., and Aitio, A., and Becking, G. (2001) ―Arsenic and Arsenic Compounds‖, 
Environmental Health Criteria 224, 1-3, Genera, World Health Organization.  
Gonsebatt, M.E., Vega, L., Salazar, A.M., Montero, R., Guzman, P., Blas, J., Del Razo, 
L.M., Garcia-Vargas, G., Albores, A., Cebrian, M.E., Kelsh, M., and Ostrosky-Wegman, 
P. (1997) ―Cytogenetic effects in human exposure to arsenic‖. Mutation Research, 386: 
219–228. 
Goyens P., Golstein J., Nsombola B., Vis H. and Dumont J. E. (1987) ―Selenium 
deficiency as a possible factor in the pathogenesis of myxoedematous endemic cretinism‖. 
Acta Endocrinologica, 114: 497-502. 
Guha Mazumder, D.N. (2008) ―Chronic arsenic toxicity & human health‖. Indian 
Journal of medical research, 28:436-447. 
Hayakawa, T., Kobayashi, Y., Cui, X., and Hirano, S. (2005) ―A new metabolic pathway 
of arsenite: Arsenic-glutathione complexes are substrates for human arsenic 
methyltransferase Cyt19‖. Achieves of Toxicology, 79: 183–191. 
Hirakawa, H. (2001) "Coprophagy in Leporids and Other Mammalian Herbivores". 
Mammal Review, 31: 61–80. 
House, J. E. (2008) ―Inorganic chemistry‖, 524, London, Academic Press.  
Huerga, A., Lavilla, I., and Bendicho, C. (2005) ―Speciation of the immediately 
mobilisable As(III), As(V), MMA and DMA in river sediments by high performance 
101 
 
liquid chromatography–hydride generation–atomic fluorescence spectrometry following 
ultrasonic extraction‖.  Analytica Chimica Acta, 534: 121-128. 
Hughes, M.F. (2002) ―Arsenic toxicity and potential mechanisms of action.‖ Toxicology 
letters, 133: 1-6.  
Hutchinson, J. (1987) ―Arsenic and cancer‖. British Medical Journal, 2: 1280–1281 
Institute of Medicine, Food and Nutrition Board. (2000) ―Dietary Reference Intakes: 
Vitamin C, Vitamin E, Selenium, and Carotenoids‖. Washington, DC, National Academy 
Press. 
Jones, D.P., Carlson, J.L., Mody, V.C., Cai, J., Lynn, M.J., and Sternberg, P. (2000) 
―Redox state of glutathione in human plasma‖. Free Radical Biology & Medicine, 
28:625-635. 
Kudo, K. (1965) ―Optical Properties of Plane-Grating Monochromator‖.  Journal of the 
Optical Society of America, 55: 150-161  
Leng, L., Bobček, R., Kuricova, S., Boldizarova, K., Grešakova, L., Ševcikova, Z., 
Revajova, V., Levkutova, M., and Levkut, M. (2003) ―Comparative metabolic and 
immune responses of chickens fed diets containing inorganic selenium and Sel-PlexTM 
organic selenium‖. In Lyons T.P., Jacques K.A. (eds.), Nutritional Biotechnology in the 
Feed and Food Industries, 131–145. Nottingham, U.K., Nottingham University Press. 
Levander, O. A. (1977) ―Metabolic interrelationships between arsenic and selenium‖. 
Environmental Health Perspectives, 19:159-164 
102 
 
Lu, M., Wang, H., Li, X. F., Lu, X., Cullen, W. R., Arnold, L. L., Cohen, S. M., and Le, 
X. C. (2004) ―Evidence of hemoglobin binding to arsenic as a basis for the accumulation 
of arsenic in rat blood‖. Chemical Research in Toxicology, 17: 1733-1742. 
Mäki-Paakkanen, J., Kurttio P., Paldy, A., and Pekkanen, J. (1998) ―Association between 
the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through 
drinking water‖. Environmental and Molecular Mutagenesis, 32: 301–13. 
Männistö, S., Alfthan, G., Virtanen, M., Kataja, V., Uusitupa, M., and Pietinen, P. (2000) 
―Toenail selenium and breast cancer ---a case-control study in Finland‖, European 
Journal of Clinical Nutrition, 54: 98-103. 
Masters, A. F. (2009) "Allotropes - Group 13, Group 14, Group 15, Group 16". 
Chemistry Explained.  http://www.chemistryexplained.com/A-Ar/Allotropes.html 
Moreno-Reyes, R., Suetens, C., Mathieu, F., Begaux, F., Zhu, D., Rivera, M.T., Boelaert, 
M., Neve, J., Perlmutter, N., and Vanderpas, J. (1998) ―Kashin-Beck osteoarthropathy in 
rural Tibet in relation to selenium and iodine status‖. The New England Journal of 
Medicine, 339: 1112–20. 
Mortoza, S. (1997) ―Arsenic contamination: searching for solutions-1997‖. 
<http://bicn.com/acic/resources/infobank/mortoza/mortoza1.htm> 
Moxon, A.L. (1938) ―The Effect of Arsenic on the Toxicity of Seleniferous Grains‖. 
Science, 88:81–81 
NTP, (National Toxicology Program), (2000). ―Arsenic and certain arsenic compounds‖. 
Reports on Carcinogens, First and Subsequent 2nd–9th (1980–2000), 17–19. Research 
Triangle Park, NC. 
103 
 
Patrick, L. (1999) ―Nutrients and HIV: part one ─ beta carotene and selenium‖. 
Alternative Medicine Review, 4: 403–13 
Petrick, J. S., Ayala-Fierro, F., Cullen, W. R., Carter, D. E., and Aposhian, H. V. (2000) 
―Monomethylarsonous acid MMA(III) is more toxic than arsenite in Chang human 
hepatocytes‖. Toxicology and Applied Pharmacology, 163: 203-207. 
Petrusevski, B., Sharma, S.K., and Schippers, J.C. (2005) Arsenic in drinking water (Part 
I). Voda i Sanitarna Technika, 35: 11-18. 
Pickering, I.J., Prince, R.C., Divers, T., and George, G.N. (1998) ―Sulfur K-edge X-ray 
Absorption spectroscopy for determining the chemical speciation of sulfur in biological 
systems‖. FEBS Letters, 441:11-14. 
Rahman, F.A., Allan, D.L., Rosen, C.J., Sadowsky, M.J. (2004). ―Arsenic availability 
from chromated copper arsenate (CCA)-treated wood.‖ Journal of environmental quality 
33: 173–80. 
Robert, K. C., and Lipmann, F. (1953) ―The effect of arsenate on aerobic 
phosphorylation‖. Journal of Biological Chemistry, 201: 235-243. 
Robson, A. O. and Jelliffe, A. M.  (1963) ―Medicinal Arsenic Poisoning and Lung 
Cancer‖. British Medical Journal, 2: 5351.  
Roy, P., and Saha, A. (2002) ―Metabolism and toxicity of arsenic: A human carcinogen‖. 
Current Science, 82:38-45. 
Russo, M.W., and Murray, S.C. (1997) ―Plasma selenium levels and the risk of colorectal 
adenomas‖, Nutrition and Cancer, 28: 125-129. 
104 
 
Ruyle, G. (2009) "Poisonous Plants on Arizona Rangelands". The University of 
Arizona.<http://cals.arizona.edu/arec/pubs/rmg/1%20rangelandmanagement/2%20poison
ousplants93.pdf> 
Schafer, F.Q., and Buettner, G.R. (2001) ―Redox Environment of the cell as viewed 
through the redox state of the glutathione disulfide/glutathione couple‖. Free Radical 
Biology & Medicine, 30:1191-1212. 
Schulze, D.G., and Bertsch, P.M. (1995) ―Synchrotron X-ray techniques in soil, plant, 
and environmental research‖. Advances in Agronomy, 55:1-66. 
  Sheng, T., (2003) ―L. Selenium‖. Chemical and Engineering News, 81: 94. 
Steiner-Asiedu, M., Anderson, A.K., Vuvor, F., and Asiedu, D.K. (2010) ―Exposure to 
Arsenic in Drinking Water-Public Health Debates and Concerns‖. Research Journal of 
Environmental and Earth Sciences, 2: 1-5. 
Styblo, M., Del Razo, L.M., Vega, L., Germolec, D. R., Lecluyse, E.L., Hamilton, G.A., 
Reed, W., Wang, C. Cullen, W.R., and Thomas, D.J. (2000) ―Comparative toxicity of 
trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells”. 
Achieves of Toxicology, 74:289-299. 
Teo, B.K. (1986) ―EXAFS: basic principles and data analysis‖. 349-351, Berlin and New 
York, Springer-Verlag. 
Thavarajah, D., Vandenberg, A., George, G. N., and Pickering, I. J. (2007) ―The 
Chemical Form of Selenium in Naturally Selenium-Rich Lentils (Lens culinaris L.) from 
Saskatchewan‖, Journal of Agricultural and Food Chemistry, 55:7337-7341. 
105 
 
Theil, E. C., Sayers, D. E., and Brown, M. A. (1979) ―Similarity of Structure of Ferritin 
and Iron Dextran (Imferon) Determined by Extended X-ray Absorption Fine Structure 
Analysis‖. The Journal of Biological Chemistry, 254: 8132-8134 
Thomas, D. J., Styblo, M., and Lin, S. (2001) ―The cellular metabolism and systemic 
toxicity of arsenic‖. Toxicology and Applied Pharmacology, 176: 127–144. 
Utiger, R. D. (1998) ―Kashin–Beck Disease — Expanding the Spectrum of Iodine-
Deficiency Disorders‖. The New England Journal of Medicine, 339:1156-1158. 
Vahter, M. (1994) ―Species differences in the metabolism of arsenic compounds‖. 
Applied Organometallic Chemistry, 8: 175-182. 
Van Elp, J., Peng, G., Zhou, Z.H., Adams, M.W.W., Baidya, N., Mascharak, P.K., and 
Cramer, S.P. (1995) ―Nickel L-Edge X-ray Absorption Spectroscopy of Pyrococcus 
furiosus Hydrogenase‖. Inorganic Chemistry, 34:2501-2504. 
Vendeland, S.C., Butler, J.A., and Whanger, P.D. (1992) ―Intestinal absorption of 
selenite, selenate, and selenomethionine in the rat‖. The Journal of Nutritional 
Biochemistry, 3:359-365. 
Vigo, J. B., and Ellzey, J. T. (2006) ―Effects of Arsenic Toxicity at the Cellular Level: A 
Review‖. Texas Journal of Microscopy, 37: 45–49. 
Villamor, E., Mugusi, F., Urassa, W., Bosch, R.J., Saathoff, E., Matsumoto, K., Meydani, 
S.N., and Fawzi, W.W. (2008) ―A trial of the effect of micronutrient supplementation on 
treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary 
tuberculosis‖. The Journal of Infectious Diseases, 197: 1499–505.  
106 
 
Warner, M.L., Moore, L.E., Smith, M.T., Kalman, D.A., Fanning, E., and Smith, A.H. 
(1994) ―Increased micronuclei in exfoliated bladder cells of individuals who chronically 
ingest arsenic-contaminated water in Nevada‖. Cancer Epidemiology, Biomarkers & 
Prevention, 3: 583–90. 
Watanabe, C. (2002) "Modification of mercury toxicity by selenium: practical 
importance?‖ The Tohoku Journal of Experimental Medicine, 196: 71–7. 
Whanger, P. D. (2002) ―Selenocompounds in Plants and Animals and their Biological 
Significance‖ Journal of the American College of Nutrition, 21:223–232. 
 WHO (World Health Organization), (2001) ―Arsenic in drinking water‖, Fact sheet 
N
o
210, <http://www.who.int/mediacentre/factsheets/fs210/en/print.html> 
Zeng, H., Uthus, E.O., Combs Jr, G.F. (2005) ―Mechanistic aspects of the interaction 
between selenium and arsenic‖. Journal of inorganic chemistry ,99:1269-1274. 
Zhang, J.S., Gao, X.Y., Zhang, L.D., and Bao, Y.P. (2001) ―Biological effects of a nano 
red elemental selenium‖. Biofactors, 15:27–38. 
